These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
x
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
o
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Maryland
|
|
38-3754322
|
|
(State or Other Jurisdiction of
|
|
(IRS Employer
|
|
Incorporation of Organization)
|
|
Identification No.)
|
|
|
|
|
|
|
|
|
|
299 Park Avenue, 13th Floor, New York, New York
|
|
10171
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.001 per share
|
TIPT
|
Nasdaq Capital Market
|
|
ITEM
|
|
Page Number
|
|
|
||
|
Item 1. Financial Statements (Unaudited)
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
(5) Investments
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
(14) Other Assets and Other Liabilities and Accrued Expenses
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Assets:
|
|
|
|
||||
|
Investments:
|
|
|
|
||||
|
Available for sale securities, at fair value
|
$
|
283,929
|
|
|
$
|
283,563
|
|
|
Loans, at fair value
|
125,145
|
|
|
215,383
|
|
||
|
Equity securities
|
122,592
|
|
|
122,979
|
|
||
|
Other investments
|
76,741
|
|
|
75,002
|
|
||
|
Total investments
|
608,407
|
|
|
696,927
|
|
||
|
Cash and cash equivalents
|
88,079
|
|
|
86,003
|
|
||
|
Restricted cash
|
13,062
|
|
|
10,521
|
|
||
|
Notes and accounts receivable, net
|
231,990
|
|
|
223,105
|
|
||
|
Reinsurance receivables
|
420,996
|
|
|
420,351
|
|
||
|
Deferred acquisition costs
|
170,727
|
|
|
170,063
|
|
||
|
Goodwill
|
91,562
|
|
|
91,562
|
|
||
|
Intangible assets, net
|
50,098
|
|
|
52,121
|
|
||
|
Other assets
|
70,465
|
|
|
46,034
|
|
||
|
Assets held for sale
|
69,454
|
|
|
68,231
|
|
||
|
Total assets
|
$
|
1,814,840
|
|
|
$
|
1,864,918
|
|
|
|
|
|
|
||||
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
|
Liabilities:
|
|
|
|
||||
|
Debt, net
|
$
|
282,798
|
|
|
$
|
354,083
|
|
|
Unearned premiums
|
589,074
|
|
|
599,444
|
|
||
|
Policy liabilities and unpaid claims
|
130,585
|
|
|
131,611
|
|
||
|
Deferred revenue
|
75,276
|
|
|
75,754
|
|
||
|
Reinsurance payable
|
115,029
|
|
|
117,597
|
|
||
|
Other liabilities and accrued expenses
|
163,224
|
|
|
124,190
|
|
||
|
Liabilities held for sale
|
64,199
|
|
|
62,980
|
|
||
|
Total liabilities
|
$
|
1,420,185
|
|
|
$
|
1,465,659
|
|
|
|
|
|
|
||||
|
Stockholders’ Equity:
|
|
|
|
||||
|
Preferred stock: $0.001 par value, 100,000,000 shares authorized, none issued or outstanding
|
$
|
—
|
|
|
$
|
—
|
|
|
Common Stock: $0.001 par value, 200,000,000 shares authorized, 34,505,781 and 35,870,348 shares issued and outstanding, respectively
|
35
|
|
|
36
|
|
||
|
Additional paid-in capital
|
323,334
|
|
|
331,892
|
|
||
|
Accumulated other comprehensive income (loss), net of tax
|
251
|
|
|
(2,058
|
)
|
||
|
Retained earnings
|
60,015
|
|
|
57,231
|
|
||
|
Total Tiptree Inc. stockholders’ equity
|
383,635
|
|
|
387,101
|
|
||
|
Non-controlling interests - Other
|
11,020
|
|
|
12,158
|
|
||
|
Total stockholders’ equity
|
394,655
|
|
|
399,259
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
1,814,840
|
|
|
$
|
1,864,918
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Revenues:
|
|
|
|
||||
|
Earned premiums, net
|
$
|
118,973
|
|
|
$
|
101,645
|
|
|
Service and administrative fees
|
25,895
|
|
|
24,576
|
|
||
|
Ceding commissions
|
2,504
|
|
|
2,283
|
|
||
|
Net investment income
|
4,301
|
|
|
4,205
|
|
||
|
Net realized and unrealized gains (losses)
|
20,151
|
|
|
7,384
|
|
||
|
Other revenue
|
12,079
|
|
|
7,979
|
|
||
|
Total revenues
|
183,903
|
|
|
148,072
|
|
||
|
Expenses:
|
|
|
|
||||
|
Policy and contract benefits
|
40,841
|
|
|
36,626
|
|
||
|
Commission expense
|
74,903
|
|
|
62,633
|
|
||
|
Employee compensation and benefits
|
29,153
|
|
|
27,788
|
|
||
|
Interest expense
|
6,920
|
|
|
5,946
|
|
||
|
Depreciation and amortization
|
3,094
|
|
|
2,957
|
|
||
|
Other expenses
|
23,837
|
|
|
19,165
|
|
||
|
Total expenses
|
178,748
|
|
|
155,115
|
|
||
|
Income (loss) before taxes from continuing operations
|
5,155
|
|
|
(7,043
|
)
|
||
|
Less: provision (benefit) for income taxes
|
854
|
|
|
(1,568
|
)
|
||
|
Net income (loss) from continuing operations
|
4,301
|
|
|
(5,475
|
)
|
||
|
Discontinued operations:
|
|
|
|
||||
|
Income (loss) before taxes from discontinued operations
|
—
|
|
|
624
|
|
||
|
Gain on sale of discontinued operations
|
—
|
|
|
46,184
|
|
||
|
Less: Provision (benefit) for income taxes
|
—
|
|
|
12,327
|
|
||
|
Net income (loss) from discontinued operations
|
—
|
|
|
34,481
|
|
||
|
Net income (loss) before non-controlling interests
|
4,301
|
|
|
29,006
|
|
||
|
Less: net income (loss) attributable to non-controlling interests - TFP
|
—
|
|
|
5,392
|
|
||
|
Less: net income (loss) attributable to non-controlling interests - Other
|
376
|
|
|
54
|
|
||
|
Net income (loss) attributable to Common Stockholders
|
$
|
3,925
|
|
|
$
|
23,560
|
|
|
|
|
|
|
||||
|
Net income (loss) per Common Share:
|
|
|
|
||||
|
Basic, continuing operations, net
|
$
|
0.11
|
|
|
$
|
(0.15
|
)
|
|
Basic, discontinued operations, net
|
—
|
|
|
0.94
|
|
||
|
Basic earnings per share
|
$
|
0.11
|
|
|
$
|
0.79
|
|
|
|
|
|
|
||||
|
Diluted, continuing operations, net
|
0.11
|
|
|
(0.15
|
)
|
||
|
Diluted, discontinued operations, net
|
—
|
|
|
0.94
|
|
||
|
Diluted earnings per share
|
$
|
0.11
|
|
|
$
|
0.79
|
|
|
|
|
|
|
||||
|
Weighted average number of Common Shares:
|
|
|
|
||||
|
Basic
|
34,673,054
|
|
|
29,861,496
|
|
||
|
Diluted
|
34,673,054
|
|
|
29,861,496
|
|
||
|
|
|
|
|
||||
|
Dividends declared per Common Share
|
$
|
0.040
|
|
|
$
|
0.035
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net income (loss) before non-controlling interests
|
$
|
4,301
|
|
|
$
|
29,006
|
|
|
|
|
|
|
||||
|
Other comprehensive income (loss), net of tax:
|
|
|
|
||||
|
Unrealized gains (losses) on available-for-sale securities:
|
|
|
|
||||
|
Unrealized holding gains (losses) arising during the period
|
3,128
|
|
|
(2,293
|
)
|
||
|
Related tax (expense) benefit
|
(713
|
)
|
|
504
|
|
||
|
Reclassification of (gains) losses included in net income
|
5
|
|
|
527
|
|
||
|
Related tax expense (benefit)
|
(1
|
)
|
|
(112
|
)
|
||
|
Unrealized gains (losses) on available-for-sale securities, net of tax
|
2,419
|
|
|
(1,374
|
)
|
||
|
|
|
|
|
||||
|
Interest rate swaps (cash flow hedges):
|
|
|
|
||||
|
Unrealized gains (losses) on interest rate swaps
|
—
|
|
|
1,111
|
|
||
|
Related tax (expense) benefit
|
—
|
|
|
(276
|
)
|
||
|
Reclassification of (gains) losses included in net income
(1)
|
—
|
|
|
(3,845
|
)
|
||
|
Related tax expense (benefit)
|
—
|
|
|
936
|
|
||
|
Unrealized (losses) gains on interest rate swaps from cash flow hedges, net of tax
|
—
|
|
|
(2,074
|
)
|
||
|
|
|
|
|
||||
|
Other comprehensive income (loss), net of tax
|
2,419
|
|
|
(3,448
|
)
|
||
|
Comprehensive income (loss)
|
6,720
|
|
|
25,558
|
|
||
|
Less: Comprehensive income (loss) attributable to non-controlling interests - TFP
|
—
|
|
|
4,829
|
|
||
|
Less: Comprehensive income (loss) attributable to non-controlling interests - Other
|
387
|
|
|
(382
|
)
|
||
|
Comprehensive income (loss) attributable to Common Stockholders
|
$
|
6,333
|
|
|
$
|
21,111
|
|
|
(1)
|
Deconsolidated as part of the sale of Care. See Note
(3) Dispositions, Assets Held for Sale & Discontinued Operations
.
|
|
|
Number of Shares
|
|
Par Value
|
|
Additional paid in capital
|
|
Accumulated
other comprehensive income (loss) |
|
Retained
earnings |
|
Shares held by subsidiaries
|
|
Total stockholders’ equity to Tiptree Inc.
|
|
Non-controlling
interests - TFP |
|
Non-controlling
interests - Other |
|
Total stockholders' equity
|
||||||||||||||||||||||||||||||||||||
|
|
Common Stock
|
|
Class B
|
|
Common Stock
|
|
Class B
|
|
|
|
|
Common Stock
|
|
Common Stock Amount
|
|
Class B Shares
|
|
Class B Amount
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
Balance at December 31, 2017
|
35,003,004
|
|
|
8,049,029
|
|
|
$
|
35
|
|
|
$
|
8
|
|
|
$
|
295,582
|
|
|
$
|
966
|
|
|
$
|
38,079
|
|
|
(5,197,551
|
)
|
|
$
|
(34,585
|
)
|
|
(8,049,029
|
)
|
|
$
|
(8
|
)
|
|
$
|
300,077
|
|
|
$
|
77,494
|
|
|
$
|
19,203
|
|
|
$
|
396,774
|
|
|
Amortization of share based incentive compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
585
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
585
|
|
|
—
|
|
|
648
|
|
|
1,233
|
|
|||||||||||
|
Vesting of share-based incentive compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,003
|
)
|
|
—
|
|
|
—
|
|
|
145,973
|
|
|
949
|
|
|
—
|
|
|
—
|
|
|
(54
|
)
|
|
—
|
|
|
—
|
|
|
(54
|
)
|
|||||||||||
|
Other comprehensive income, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,449
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,449
|
)
|
|
(563
|
)
|
|
(436
|
)
|
|
(3,448
|
)
|
|||||||||||
|
Non-controlling interest distributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(241
|
)
|
|
—
|
|
|
(241
|
)
|
|||||||||||
|
Shares purchased under stock purchase plan
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(29,365
|
)
|
|
(187
|
)
|
|
—
|
|
|
—
|
|
|
(187
|
)
|
|
—
|
|
|
—
|
|
|
(187
|
)
|
|||||||||||
|
Net changes in non-controlling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(486
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(486
|
)
|
|
—
|
|
|
(14,039
|
)
|
|
(14,525
|
)
|
|||||||||||
|
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(898
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(898
|
)
|
|
—
|
|
|
—
|
|
|
(898
|
)
|
|||||||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
23,560
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
23,560
|
|
|
5,392
|
|
|
54
|
|
|
29,006
|
|
|||||||||||
|
Balance at March 31, 2018
|
35,003,004
|
|
|
8,049,029
|
|
|
$
|
35
|
|
|
$
|
8
|
|
|
$
|
294,678
|
|
|
$
|
(1,483
|
)
|
|
$
|
60,741
|
|
|
(5,080,943
|
)
|
|
$
|
(33,823
|
)
|
|
(8,049,029
|
)
|
|
$
|
(8
|
)
|
|
$
|
320,148
|
|
|
$
|
82,082
|
|
|
$
|
5,430
|
|
|
$
|
407,660
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
Number of shares
|
|
Par value
|
|
Additional paid in capital
|
|
Accumulated other comprehensive income (loss)
|
|
Retained earnings
|
|
Total stockholders’ equity to Tiptree Inc.
|
|
Non-controlling interests - Other
|
|
Total stockholders' equity
|
|||||||||||||||
|
Balance at December 31, 2018
|
35,870,348
|
|
|
$
|
36
|
|
|
$
|
331,892
|
|
|
$
|
(2,058
|
)
|
|
$
|
57,231
|
|
|
$
|
387,101
|
|
|
$
|
12,158
|
|
|
$
|
399,259
|
|
|
Adoption of accounting standard
(1)
|
—
|
|
|
—
|
|
|
—
|
|
|
(99
|
)
|
|
99
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Amortization of share-based incentive compensation
|
—
|
|
|
—
|
|
|
670
|
|
|
—
|
|
|
—
|
|
|
670
|
|
|
661
|
|
|
1,331
|
|
|||||||
|
Vesting of share-based incentive compensation
|
108,163
|
|
|
—
|
|
|
(144
|
)
|
|
—
|
|
|
—
|
|
|
(144
|
)
|
|
(2,236
|
)
|
|
(2,380
|
)
|
|||||||
|
Shares purchased under stock purchase plan
|
(1,472,730
|
)
|
|
(1
|
)
|
|
(9,084
|
)
|
|
—
|
|
|
—
|
|
|
(9,085
|
)
|
|
—
|
|
|
(9,085
|
)
|
|||||||
|
Non-controlling interest contributions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
50
|
|
|
50
|
|
|||||||
|
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,240
|
)
|
|
(1,240
|
)
|
|
—
|
|
|
(1,240
|
)
|
|||||||
|
Other comprehensive income, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
2,408
|
|
|
—
|
|
|
2,408
|
|
|
11
|
|
|
2,419
|
|
|||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,925
|
|
|
3,925
|
|
|
376
|
|
|
4,301
|
|
|||||||
|
Balance at March 31, 2019
|
34,505,781
|
|
|
$
|
35
|
|
|
$
|
323,334
|
|
|
$
|
251
|
|
|
$
|
60,015
|
|
|
$
|
383,635
|
|
|
$
|
11,020
|
|
|
$
|
394,655
|
|
|
(1)
|
Amounts reclassified due to adoption of ASU 2018-02. See Note
(2) Summary of Significant Accounting Policies
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Operating Activities:
|
|
|
|
||||
|
Net income (loss) attributable to Common Stockholders
|
$
|
3,925
|
|
|
$
|
23,560
|
|
|
Net income (loss) attributable to non-controlling interests - TFP
|
—
|
|
|
5,392
|
|
||
|
Net income (loss) attributable to non-controlling interests - Other
|
376
|
|
|
54
|
|
||
|
Net income (loss)
|
4,301
|
|
|
29,006
|
|
||
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities
|
|
|
|
||||
|
Net realized and unrealized (gains) losses
|
(20,151
|
)
|
|
(7,384
|
)
|
||
|
Net (gain) on sale of subsidiary
|
—
|
|
|
(46,184
|
)
|
||
|
Non cash compensation expense
|
1,408
|
|
|
1,233
|
|
||
|
Amortization/accretion of premiums and discounts
|
308
|
|
|
169
|
|
||
|
Depreciation and amortization expense
|
3,094
|
|
|
2,958
|
|
||
|
Bad debt expense
|
80
|
|
|
64
|
|
||
|
Amortization of deferred financing costs
|
240
|
|
|
329
|
|
||
|
Loss on extinguishment of debt
|
1,241
|
|
|
428
|
|
||
|
Deferred tax expense (benefit)
|
727
|
|
|
10,759
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Mortgage loans originated for sale
|
(350,220
|
)
|
|
(360,542
|
)
|
||
|
Proceeds from the sale of mortgage loans originated for sale
|
366,121
|
|
|
390,747
|
|
||
|
(Increase) decrease in notes and accounts receivable
|
(5,020
|
)
|
|
(15,234
|
)
|
||
|
(Increase) decrease in reinsurance receivables
|
(645
|
)
|
|
(9,444
|
)
|
||
|
(Increase) decrease in deferred acquisition costs
|
(664
|
)
|
|
4,016
|
|
||
|
(Increase) decrease in other assets
|
2,201
|
|
|
(18,361
|
)
|
||
|
Increase (decrease) in unearned premiums
|
(10,370
|
)
|
|
17,639
|
|
||
|
Increase (decrease) in policy liabilities and unpaid claims
|
(1,026
|
)
|
|
5,737
|
|
||
|
Increase (decrease) in deferred revenue
|
(478
|
)
|
|
1,604
|
|
||
|
Increase (decrease) in reinsurance payable
|
(2,568
|
)
|
|
5,624
|
|
||
|
Increase (decrease) in other liabilities and accrued expenses
|
3,261
|
|
|
(9,713
|
)
|
||
|
Net cash provided by (used in) operating activities
|
(8,160
|
)
|
|
3,451
|
|
||
|
|
|
|
|
||||
|
Investing Activities:
|
|
|
|
||||
|
Purchases of investments
|
(30,725
|
)
|
|
(104,449
|
)
|
||
|
Proceeds from sales and maturities of investments
|
120,309
|
|
|
76,291
|
|
||
|
Proceeds from the sale of real estate
|
2,555
|
|
|
4,200
|
|
||
|
Purchases of fixed assets
|
(3,231
|
)
|
|
(614
|
)
|
||
|
Proceeds from the sale of subsidiaries
|
9,676
|
|
|
3,561
|
|
||
|
Proceeds from notes receivable
|
7,711
|
|
|
7,803
|
|
||
|
Issuance of notes receivable
|
(11,629
|
)
|
|
(7,778
|
)
|
||
|
Net cash provided by (used in) investing activities
|
94,666
|
|
|
(20,986
|
)
|
||
|
|
|
|
|
||||
|
Financing Activities:
|
|
|
|
||||
|
Non-controlling interest contributions
|
50
|
|
|
—
|
|
||
|
Non-controlling interest distributions
|
—
|
|
|
(241
|
)
|
||
|
Payment of debt issuance costs
|
(37
|
)
|
|
(346
|
)
|
||
|
Proceeds from borrowings and mortgage notes payable
|
382,506
|
|
|
363,590
|
|
||
|
Principal paydowns of borrowings and mortgage notes payable
|
(455,414
|
)
|
|
(395,625
|
)
|
||
|
Repurchases of Common Stock
|
(9,085
|
)
|
|
(187
|
)
|
||
|
Net cash provided by (used in) financing activities
|
(81,980
|
)
|
|
(32,809
|
)
|
||
|
Net increase (decrease) in cash, cash equivalents and restricted cash
|
4,526
|
|
|
(50,344
|
)
|
||
|
Cash, cash equivalents and restricted cash – beginning of period
|
96,524
|
|
|
142,237
|
|
||
|
Cash, cash equivalents and restricted cash – beginning of period - held for sale
|
2,860
|
|
|
10,533
|
|
||
|
Cash, cash equivalents and restricted cash – end of period
(
1)
|
103,910
|
|
|
102,426
|
|
||
|
Less: Reclassification of cash to assets held for sale
|
2,769
|
|
|
1,871
|
|
||
|
Cash, cash equivalents and restricted cash– end of period
|
$
|
101,141
|
|
|
$
|
100,555
|
|
|
|
|
|
|
||||
|
Supplemental Schedule of Non-Cash Investing and Financing Activities:
|
|
|
|
||||
|
Right-of-use asset obtained in exchange for lease liability
|
$
|
33,558
|
|
|
$
|
—
|
|
|
Acquired real estate properties through, or in lieu of, foreclosure of the related loan
|
$
|
1,958
|
|
|
$
|
3,435
|
|
|
Equity securities acquired through the sale of a subsidiary and asset sales
|
$
|
—
|
|
|
$
|
134,083
|
|
|
|
|
|
|
||||
|
|
As of
|
||||||
|
Reconciliation of cash, cash equivalents and restricted cash shown in the statement of cash flows
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Cash and cash equivalents
|
$
|
88,079
|
|
|
$
|
86,003
|
|
|
Restricted cash
|
13,062
|
|
|
10,521
|
|
||
|
Total cash, cash equivalents and restricted cash shown in the statement of cash flows
|
$
|
101,141
|
|
|
96,524
|
|
|
|
(1)
|
Includes cash in assets held for sale
|
|
•
|
Fair value of financial assets and liabilities, including, but not limited to, securities, loans and derivatives;
|
|
•
|
Value of acquired assets and liabilities;
|
|
•
|
Carrying value of goodwill and other intangibles, including estimated amortization period and useful lives;
|
|
•
|
Reserves for unpaid losses and loss adjustment expenses, estimated future claims and losses, potential litigation and other claims;
|
|
•
|
Valuation of contingent share issuances for compensation and purchase consideration, including estimates of number of shares and vesting schedules;
|
|
•
|
Revenue recognition including, but not limited to, the timing and amount of insurance premiums, service, administration fees, and loan origination fees; and
|
|
•
|
Other matters that affect the reported amounts and disclosure of contingencies in the condensed consolidated financial statements.
|
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Assets
|
|
|
|
||||
|
Investments:
|
|
|
|
||||
|
Loans, at fair value
|
$
|
63,372
|
|
|
$
|
63,340
|
|
|
Other investments
|
1,283
|
|
|
798
|
|
||
|
Total Investments
|
64,655
|
|
|
64,138
|
|
||
|
Cash and cash equivalents
|
2,769
|
|
|
2,860
|
|
||
|
Notes and accounts receivable, net
|
203
|
|
|
230
|
|
||
|
Other assets
(1)
|
1,827
|
|
|
1,003
|
|
||
|
Assets held for sale
|
$
|
69,454
|
|
|
$
|
68,231
|
|
|
|
|
|
|
||||
|
Liabilities
|
|
|
|
||||
|
Debt, net
|
$
|
61,602
|
|
|
$
|
61,381
|
|
|
Other liabilities and accrued expenses
(2)
|
2,597
|
|
|
1,599
|
|
||
|
Liabilities held for sale
|
$
|
64,199
|
|
|
$
|
62,980
|
|
|
(1)
|
Includes
$582
and
$0
of a right of use asset as of March 31, 2019 and December 31, 2018, respectively.
|
|
(2)
|
Includes
$601
and
$0
of a lease liability as of March 31, 2019 and December 31, 2018, respectively.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Revenues:
|
|
|
|
||||
|
Rental and related revenue
|
$
|
—
|
|
|
$
|
6,476
|
|
|
Other revenue
|
—
|
|
|
149
|
|
||
|
Total revenues
|
—
|
|
|
6,625
|
|
||
|
Expenses:
|
|
|
|
||||
|
Employee compensation and benefits
|
—
|
|
|
2,788
|
|
||
|
Interest expense
|
—
|
|
|
1,252
|
|
||
|
Other expenses
|
—
|
|
|
1,961
|
|
||
|
Total expenses
|
—
|
|
|
6,001
|
|
||
|
Net income (loss) before taxes from discontinued operations
|
—
|
|
|
624
|
|
||
|
Gain on sale of discontinued operations
|
—
|
|
|
46,184
|
|
||
|
Less: provision (benefit) for income taxes
|
—
|
|
|
12,327
|
|
||
|
Net income (loss) from discontinued operations
|
$
|
—
|
|
|
$
|
34,481
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net cash provided by (used in):
|
|
|
|
||||
|
Operating activities
|
$
|
—
|
|
|
$
|
(2,095
|
)
|
|
Investing activities
|
—
|
|
|
(592
|
)
|
||
|
Financing activities
|
—
|
|
|
(123
|
)
|
||
|
Net cash flows provided by discontinued operations
|
$
|
—
|
|
|
$
|
(2,810
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, 2019 |
|
Three Months Ended
March 31, 2018 |
||||||||||||||||||||
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
||||||||||||
|
Total revenue
|
$
|
154,628
|
|
|
$
|
29,275
|
|
|
$
|
183,903
|
|
|
$
|
129,998
|
|
|
$
|
18,074
|
|
|
$
|
148,072
|
|
|
Total expense
|
(146,490
|
)
|
|
(23,357
|
)
|
|
(169,847
|
)
|
|
(128,655
|
)
|
|
(19,746
|
)
|
|
(148,401
|
)
|
||||||
|
Corporate expense
|
—
|
|
|
—
|
|
|
(8,901
|
)
|
|
—
|
|
|
—
|
|
|
(6,714
|
)
|
||||||
|
Net income (loss) before taxes from continuing operations
|
$
|
8,138
|
|
|
$
|
5,918
|
|
|
$
|
5,155
|
|
|
$
|
1,343
|
|
|
$
|
(1,672
|
)
|
|
$
|
(7,043
|
)
|
|
Less: provision (benefit) for income taxes
|
|
|
|
|
854
|
|
|
|
|
|
|
(1,568
|
)
|
||||||||||
|
Net income (loss) from discontinued operations
|
|
|
|
|
—
|
|
|
|
|
|
|
34,481
|
|
||||||||||
|
Net income (loss) before non-controlling interests
|
|
|
|
|
$
|
4,301
|
|
|
|
|
|
|
$
|
29,006
|
|
||||||||
|
Less: net income (loss) attributable to non-controlling interests
|
|
|
|
|
376
|
|
|
|
|
|
|
5,446
|
|
||||||||||
|
Net income (loss) attributable to Common Stockholders
|
|
|
|
|
$
|
3,925
|
|
|
|
|
|
|
$
|
23,560
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net realized and unrealized gains (losses)
(1)
|
$
|
18,037
|
|
|
$
|
10,791
|
|
|
Other investment income
(2)
|
9,881
|
|
|
5,108
|
|
||
|
Management fee income
|
1,267
|
|
|
1,577
|
|
||
|
Other
|
90
|
|
|
598
|
|
||
|
Total Revenue
|
$
|
29,275
|
|
|
$
|
18,074
|
|
|
(1)
|
See Note
(5) Investments
for the components of Net realized and unrealized gains (losses) related to Tiptree Capital.
|
|
(2)
|
See Note
(5) Investments
for the components of Other investment income.
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||||||||||||||
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Corporate
|
|
Total
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Corporate
|
|
Total
|
||||||||||||||||
|
Total assets
|
$
|
1,450,765
|
|
|
$
|
320,320
|
|
|
$
|
43,755
|
|
|
$
|
1,814,840
|
|
|
$
|
1,514,084
|
|
|
$
|
318,420
|
|
|
$
|
32,414
|
|
|
$
|
1,864,918
|
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||||||
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
||||||||||||
|
Available for sale securities, at fair value
|
$
|
283,929
|
|
|
$
|
—
|
|
|
$
|
283,929
|
|
|
$
|
283,563
|
|
|
$
|
—
|
|
|
$
|
283,563
|
|
|
Loans, at fair value
|
71,633
|
|
|
53,512
|
|
|
125,145
|
|
|
158,466
|
|
|
56,917
|
|
|
215,383
|
|
||||||
|
Equity securities
|
26,977
|
|
|
95,615
|
|
|
122,592
|
|
|
29,425
|
|
|
93,554
|
|
|
122,979
|
|
||||||
|
Other investments
|
18,751
|
|
|
57,990
|
|
|
76,741
|
|
|
18,526
|
|
|
56,476
|
|
|
75,002
|
|
||||||
|
Total investments
|
$
|
401,290
|
|
|
$
|
207,117
|
|
|
$
|
608,407
|
|
|
$
|
489,980
|
|
|
$
|
206,947
|
|
|
$
|
696,927
|
|
|
|
As of March 31, 2019
|
||||||||||||||
|
|
Amortized cost
|
|
Gross
unrealized gains |
|
Gross
unrealized losses |
|
Fair value
|
||||||||
|
U.S. Treasury securities and obligations of U.S. government authorities and agencies
|
$
|
78,903
|
|
|
$
|
595
|
|
|
$
|
(213
|
)
|
|
$
|
79,285
|
|
|
Obligations of state and political subdivisions
|
63,234
|
|
|
745
|
|
|
(197
|
)
|
|
63,782
|
|
||||
|
Corporate securities
|
93,144
|
|
|
798
|
|
|
(260
|
)
|
|
93,682
|
|
||||
|
Asset backed securities
|
42,356
|
|
|
38
|
|
|
(1,203
|
)
|
|
41,191
|
|
||||
|
Certificates of deposit
|
1,096
|
|
|
—
|
|
|
—
|
|
|
1,096
|
|
||||
|
Obligations of foreign governments
|
4,865
|
|
|
29
|
|
|
(1
|
)
|
|
4,893
|
|
||||
|
Total
|
$
|
283,598
|
|
|
$
|
2,205
|
|
|
$
|
(1,874
|
)
|
|
$
|
283,929
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
As of December 31, 2018
|
||||||||||||||
|
|
Amortized cost
|
|
Gross
unrealized gains |
|
Gross
unrealized losses |
|
Fair value
|
||||||||
|
U.S. Treasury securities and obligations of U.S. government authorities and agencies
|
$
|
71,945
|
|
|
$
|
266
|
|
|
$
|
(463
|
)
|
|
$
|
71,748
|
|
|
Obligations of state and political subdivisions
|
67,624
|
|
|
280
|
|
|
(458
|
)
|
|
67,446
|
|
||||
|
Corporate securities
|
96,888
|
|
|
78
|
|
|
(1,241
|
)
|
|
95,725
|
|
||||
|
Asset backed securities
|
41,912
|
|
|
14
|
|
|
(1,274
|
)
|
|
40,652
|
|
||||
|
Certificates of deposit
|
1,241
|
|
|
—
|
|
|
—
|
|
|
1,241
|
|
||||
|
Obligations of foreign governments
|
6,750
|
|
|
12
|
|
|
(11
|
)
|
|
6,751
|
|
||||
|
Total
|
$
|
286,360
|
|
|
$
|
650
|
|
|
$
|
(3,447
|
)
|
|
$
|
283,563
|
|
|
|
As of
|
||||||||||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||||||||||
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
|
Due in one year or less
|
$
|
32,144
|
|
|
$
|
32,107
|
|
|
$
|
30,920
|
|
|
$
|
30,836
|
|
|
Due after one year through five years
|
166,245
|
|
|
167,544
|
|
|
167,201
|
|
|
166,366
|
|
||||
|
Due after five years through ten years
|
30,208
|
|
|
30,291
|
|
|
32,805
|
|
|
32,185
|
|
||||
|
Due after ten years
|
12,645
|
|
|
12,796
|
|
|
13,522
|
|
|
13,524
|
|
||||
|
Asset-backed securities
|
42,356
|
|
|
41,191
|
|
|
41,912
|
|
|
40,652
|
|
||||
|
Total
|
$
|
283,598
|
|
|
$
|
283,929
|
|
|
$
|
286,360
|
|
|
$
|
283,563
|
|
|
|
As of March 31, 2019
|
||||||||||||||||||||
|
|
Less Than or Equal to One Year
|
|
More Than One Year
|
||||||||||||||||||
|
|
Fair value
|
|
Gross
unrealized losses |
|
# of Securities
|
|
Fair value
|
|
Gross unrealized losses
|
|
# of Securities
|
||||||||||
|
U.S. Treasury securities and obligations of U.S. government authorities and agencies
|
$
|
2,058
|
|
|
$
|
(3
|
)
|
|
15
|
|
|
$
|
21,591
|
|
|
$
|
(210
|
)
|
|
127
|
|
|
Obligations of state and political subdivisions
|
5,555
|
|
|
(3
|
)
|
|
13
|
|
|
15,093
|
|
|
(194
|
)
|
|
89
|
|
||||
|
Corporate securities
|
4,292
|
|
|
(31
|
)
|
|
32
|
|
|
23,033
|
|
|
(229
|
)
|
|
271
|
|
||||
|
Asset-backed securities
|
33,316
|
|
|
(272
|
)
|
|
12
|
|
|
2,665
|
|
|
(931
|
)
|
|
10
|
|
||||
|
Obligations of foreign governments
|
—
|
|
|
—
|
|
|
—
|
|
|
942
|
|
|
(1
|
)
|
|
4
|
|
||||
|
Total
|
$
|
45,221
|
|
|
$
|
(309
|
)
|
|
72
|
|
|
$
|
63,324
|
|
|
$
|
(1,565
|
)
|
|
501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
As of December 31, 2018
|
||||||||||||||||||||
|
|
Less Than or Equal to One Year
|
|
More Than One Year
|
||||||||||||||||||
|
|
Fair value
|
|
Gross
unrealized losses |
|
# of Securities
|
|
Fair value
|
|
Gross unrealized losses
|
|
# of Securities
|
||||||||||
|
U.S. Treasury securities and obligations of U.S. government authorities and agencies
|
$
|
14,844
|
|
|
$
|
(70
|
)
|
|
51
|
|
|
$
|
19,495
|
|
|
$
|
(393
|
)
|
|
128
|
|
|
Obligations of state and political subdivisions
|
15,830
|
|
|
(30
|
)
|
|
41
|
|
|
21,594
|
|
|
(428
|
)
|
|
115
|
|
||||
|
Corporate securities
|
47,976
|
|
|
(393
|
)
|
|
352
|
|
|
28,517
|
|
|
(848
|
)
|
|
404
|
|
||||
|
Asset-backed securities
|
37,613
|
|
|
(1,262
|
)
|
|
35
|
|
|
614
|
|
|
(12
|
)
|
|
5
|
|
||||
|
Obligations of foreign governments
|
2,313
|
|
|
(6
|
)
|
|
15
|
|
|
1,301
|
|
|
(5
|
)
|
|
8
|
|
||||
|
Total
|
$
|
118,576
|
|
|
$
|
(1,761
|
)
|
|
494
|
|
|
$
|
71,521
|
|
|
$
|
(1,686
|
)
|
|
660
|
|
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Fair value of restricted investments for special deposits required by state insurance departments
|
$
|
6,317
|
|
|
$
|
9,398
|
|
|
Fair value of restricted investments in trust pursuant to reinsurance agreements
|
26,086
|
|
|
24,931
|
|
||
|
Total fair value of restricted investments
|
$
|
32,403
|
|
|
$
|
34,329
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Purchases of available for sale securities
|
$
|
29,861
|
|
|
$
|
75,570
|
|
|
|
|
|
|
||||
|
Proceeds from maturities, calls and prepayments of available for sale securities
|
$
|
11,144
|
|
|
$
|
10,018
|
|
|
|
|
|
|
||||
|
Gains (losses) realized on maturities, calls and prepayments of available for sale securities
|
$
|
—
|
|
|
$
|
(27
|
)
|
|
|
|
|
|
||||
|
Gross proceeds from sales of available for sale securities
|
$
|
21,168
|
|
|
$
|
32,032
|
|
|
|
|
|
|
||||
|
Gains (losses) realized on sales of available for sale securities
|
$
|
(5
|
)
|
|
$
|
(500
|
)
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||||||||||||||
|
|
Fair value
|
|
Unpaid principal balance (UPB)
|
|
Fair value exceeds / (below) UPB
|
|
Pledged as Collateral
|
|
Fair value
|
|
Unpaid principal balance (UPB)
|
|
Fair value exceeds / (below) UPB
|
|
Pledged as Collateral
|
||||||||||||||||
|
Specialty Insurance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Corporate loans
(1)
|
$
|
47,094
|
|
|
$
|
51,454
|
|
|
$
|
(4,360
|
)
|
|
$
|
—
|
|
|
$
|
130,910
|
|
|
$
|
136,475
|
|
|
$
|
(5,565
|
)
|
|
$
|
120,202
|
|
|
Non-performing loans
(2)
|
24,539
|
|
|
30,545
|
|
|
(6,006
|
)
|
|
—
|
|
|
27,556
|
|
|
33,887
|
|
|
(6,331
|
)
|
|
—
|
|
||||||||
|
Tiptree Capital:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Mortgage loans held for sale
(3)
|
53,512
|
|
|
51,239
|
|
|
2,273
|
|
|
53,028
|
|
|
56,917
|
|
|
54,679
|
|
|
2,238
|
|
|
56,441
|
|
||||||||
|
Total loans, at fair value
|
$
|
125,145
|
|
|
$
|
133,238
|
|
|
$
|
(8,093
|
)
|
|
$
|
53,028
|
|
|
$
|
215,383
|
|
|
$
|
225,041
|
|
|
$
|
(9,658
|
)
|
|
$
|
176,643
|
|
|
(1)
|
The UPB of these loans approximates cost basis.
|
|
(2)
|
The cost basis of NPLs was approximately
$19,033
and
$21,555
at
March 31, 2019
and
December 31, 2018
, respectively.
|
|
(3)
|
As of
March 31, 2019
there was
one
mortgage loan held for sale with a fair value of
$123
that was 90 days or more past due. As of
December 31, 2018
there were no mortgage loans held for sale 90 days or more past due.
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||||||
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
||||||||||||
|
Invesque Inc.
|
$
|
20,015
|
|
|
$
|
95,615
|
|
|
$
|
115,630
|
|
|
$
|
19,584
|
|
|
$
|
93,554
|
|
|
$
|
113,138
|
|
|
Other equity securities
|
6,962
|
|
|
—
|
|
|
6,962
|
|
|
9,841
|
|
|
—
|
|
|
9,841
|
|
||||||
|
Total equity securities
|
$
|
26,977
|
|
|
$
|
95,615
|
|
|
$
|
122,592
|
|
|
$
|
29,425
|
|
|
$
|
93,554
|
|
|
$
|
122,979
|
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||||||
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Total
|
||||||||||||
|
Vessels, net
(1)
|
$
|
—
|
|
|
$
|
49,547
|
|
|
$
|
49,547
|
|
|
$
|
—
|
|
|
$
|
50,125
|
|
|
$
|
50,125
|
|
|
Real estate
|
9,863
|
|
|
—
|
|
|
9,863
|
|
|
10,019
|
|
|
—
|
|
|
10,019
|
|
||||||
|
Other
|
8,888
|
|
|
8,443
|
|
|
17,331
|
|
|
8,507
|
|
|
6,351
|
|
|
14,858
|
|
||||||
|
Total other investments
|
$
|
18,751
|
|
|
$
|
57,990
|
|
|
$
|
76,741
|
|
|
$
|
18,526
|
|
|
$
|
56,476
|
|
|
$
|
75,002
|
|
|
(1)
|
Net of accumulated depreciation of
$1,490
and
$898
, respectively.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Interest:
|
|
|
|
||||
|
Available for sale securities, at fair value
|
$
|
2,127
|
|
|
$
|
1,219
|
|
|
Loans, at fair value
|
1,831
|
|
|
2,472
|
|
||
|
Other investments
|
104
|
|
|
342
|
|
||
|
Dividends from equity securities
|
574
|
|
|
390
|
|
||
|
Other
|
—
|
|
|
97
|
|
||
|
Subtotal
|
4,636
|
|
|
4,520
|
|
||
|
Less: investment expenses
|
335
|
|
|
315
|
|
||
|
Net investment income
|
$
|
4,301
|
|
|
$
|
4,205
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Interest income:
|
|
|
|
||||
|
Loans, at fair value
|
$
|
1,360
|
|
|
$
|
873
|
|
|
Other
|
130
|
|
|
254
|
|
||
|
Dividends from equity securities
|
2,533
|
|
|
1,663
|
|
||
|
Loan fee income:
|
|
|
|
||||
|
Loans, at fair value
|
2,239
|
|
|
2,318
|
|
||
|
Charter revenue from vessels
|
3,619
|
|
|
—
|
|
||
|
Other investment income
|
$
|
9,881
|
|
|
$
|
5,108
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net realized gains (losses)
|
|
|
|
||||
|
Specialty Insurance:
|
|
|
|
||||
|
Reclass of unrealized gains (losses) on AFS from OCI
|
$
|
(5
|
)
|
|
$
|
(527
|
)
|
|
Net gains (losses) on loans
|
(278
|
)
|
|
1,247
|
|
||
|
Net gains (losses) on equity securities
|
482
|
|
|
2,574
|
|
||
|
Other
|
—
|
|
|
1,845
|
|
||
|
Tiptree Capital:
|
|
|
|
||||
|
Net gains (losses) on loans
|
13,587
|
|
|
15,796
|
|
||
|
Total net realized gains (losses)
|
13,786
|
|
|
20,935
|
|
||
|
|
|
|
|
||||
|
Net unrealized gains (losses)
|
|
|
|
||||
|
Specialty Insurance:
|
|
|
|
||||
|
Net change in unrealized gains (losses) on loans
|
224
|
|
|
(453
|
)
|
||
|
Net unrealized gains (losses) on equity securities held at period end
|
1,760
|
|
|
(5,926
|
)
|
||
|
Reclass of unrealized (gains) losses from prior periods for equity securities sold
|
(403
|
)
|
|
(2,167
|
)
|
||
|
Other
|
334
|
|
|
—
|
|
||
|
Tiptree Capital:
|
|
|
|
||||
|
Net change in unrealized gains (losses) on loans
|
23
|
|
|
(1,043
|
)
|
||
|
Net unrealized gains (losses) on equity securities held at period end
|
2,061
|
|
|
(3,178
|
)
|
||
|
Other
|
2,366
|
|
|
(784
|
)
|
||
|
Total net unrealized gains (losses)
|
6,365
|
|
|
(13,551
|
)
|
||
|
Total net realized and unrealized gains (losses)
|
$
|
20,151
|
|
|
$
|
7,384
|
|
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Notes receivable, net - premium financing program
|
$
|
16,338
|
|
|
$
|
13,057
|
|
|
Accounts and premiums receivable, net
|
44,867
|
|
|
50,880
|
|
||
|
Retrospective commissions receivable
|
90,339
|
|
|
84,488
|
|
||
|
Trust receivables
|
59,420
|
|
|
53,424
|
|
||
|
Other receivables
|
21,026
|
|
|
21,256
|
|
||
|
Total
|
$
|
231,990
|
|
|
$
|
223,105
|
|
|
|
Direct amount
|
|
Ceded to other companies
|
|
Assumed from other companies
|
|
Net amount
|
|
Percentage of amount - assumed to net
|
|||||||||
|
For the Three Months Ended March 31, 2019
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Premiums written:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
$
|
14,911
|
|
|
$
|
7,703
|
|
|
$
|
391
|
|
|
$
|
7,599
|
|
|
5.1
|
%
|
|
Accident and health insurance
|
27,799
|
|
|
17,975
|
|
|
747
|
|
|
10,571
|
|
|
7.1
|
%
|
||||
|
Property and liability insurance
|
137,603
|
|
|
51,819
|
|
|
17,003
|
|
|
102,787
|
|
|
16.5
|
%
|
||||
|
Total premiums written
|
180,313
|
|
|
77,497
|
|
|
18,141
|
|
|
120,957
|
|
|
15.0
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Premiums earned:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
16,449
|
|
|
8,526
|
|
|
416
|
|
|
8,339
|
|
|
5.0
|
%
|
||||
|
Accident and health insurance
|
30,613
|
|
|
20,623
|
|
|
794
|
|
|
10,784
|
|
|
7.4
|
%
|
||||
|
Property and liability insurance
|
144,994
|
|
|
60,810
|
|
|
15,666
|
|
|
99,850
|
|
|
15.7
|
%
|
||||
|
Total premiums earned
|
$
|
192,056
|
|
|
$
|
89,959
|
|
|
$
|
16,876
|
|
|
$
|
118,973
|
|
|
14.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
For the Three Months Ended March 31, 2018
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Premiums written:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
$
|
13,762
|
|
|
$
|
7,176
|
|
|
$
|
427
|
|
|
$
|
7,013
|
|
|
6.1
|
%
|
|
Accident and health insurance
|
26,626
|
|
|
17,433
|
|
|
769
|
|
|
9,962
|
|
|
7.7
|
%
|
||||
|
Property and liability insurance
|
141,742
|
|
|
66,827
|
|
|
17,328
|
|
|
92,243
|
|
|
18.8
|
%
|
||||
|
Total premiums written
|
182,130
|
|
|
91,436
|
|
|
18,524
|
|
|
109,218
|
|
|
17.0
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Premiums earned:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
15,614
|
|
|
7,822
|
|
|
453
|
|
|
8,245
|
|
|
5.5
|
%
|
||||
|
Accident and health insurance
|
28,902
|
|
|
19,617
|
|
|
818
|
|
|
10,103
|
|
|
8.1
|
%
|
||||
|
Property and liability insurance
|
129,609
|
|
|
53,931
|
|
|
7,619
|
|
|
83,297
|
|
|
9.1
|
%
|
||||
|
Total premiums earned
|
$
|
174,125
|
|
|
$
|
81,370
|
|
|
$
|
8,890
|
|
|
$
|
101,645
|
|
|
8.7
|
%
|
|
|
Direct amount
|
|
Ceded to other companies
|
|
Assumed from other companies
|
|
Net amount
|
|
Percentage of amount - assumed to net
|
|||||||||
|
For the Three Months Ended March 31, 2019
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Losses Incurred
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
$
|
9,958
|
|
|
$
|
5,904
|
|
|
$
|
(8
|
)
|
|
$
|
4,046
|
|
|
(0.2
|
)%
|
|
Accident and health insurance
|
3,330
|
|
|
2,485
|
|
|
221
|
|
|
1,066
|
|
|
20.7
|
%
|
||||
|
Property and liability insurance
|
55,918
|
|
|
35,578
|
|
|
10,341
|
|
|
30,681
|
|
|
33.7
|
%
|
||||
|
Total losses incurred
|
69,206
|
|
|
43,967
|
|
|
10,554
|
|
|
35,793
|
|
|
29.5
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
Member benefit claims
(1)
|
|
5,048
|
|
|
|
||||||||||||
|
|
Total policy and contract benefits
|
|
$
|
40,841
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
For the Three Months Ended March 31, 2018
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Losses Incurred
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Life insurance
|
$
|
10,353
|
|
|
$
|
5,672
|
|
|
$
|
162
|
|
|
$
|
4,843
|
|
|
3.3
|
%
|
|
Accident and health insurance
|
4,577
|
|
|
3,544
|
|
|
246
|
|
|
1,279
|
|
|
19.2
|
%
|
||||
|
Property and liability insurance
|
53,557
|
|
|
32,930
|
|
|
5,963
|
|
|
26,590
|
|
|
22.4
|
%
|
||||
|
Total losses incurred
|
68,487
|
|
|
42,146
|
|
|
6,371
|
|
|
32,712
|
|
|
19.5
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
Member benefit claims
(1)
|
|
3,914
|
|
|
|
||||||||||||
|
|
Total policy and contract benefits
|
|
$
|
36,626
|
|
|
|
|||||||||||
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Prepaid reinsurance premiums:
|
|
|
|
||||
|
Life
(1)
|
$
|
68,317
|
|
|
$
|
69,436
|
|
|
Accident and health
(1)
|
58,957
|
|
|
61,606
|
|
||
|
Property
|
169,507
|
|
|
178,498
|
|
||
|
Total
|
296,781
|
|
|
309,540
|
|
||
|
|
|
|
|
||||
|
Ceded claim reserves:
|
|
|
|
||||
|
Life
|
3,374
|
|
|
3,424
|
|
||
|
Accident and health
|
9,842
|
|
|
11,039
|
|
||
|
Property
|
75,678
|
|
|
75,748
|
|
||
|
Total ceded claim reserves recoverable
|
88,894
|
|
|
90,211
|
|
||
|
Other reinsurance settlements recoverable
|
35,321
|
|
|
20,600
|
|
||
|
Reinsurance receivables
|
$
|
420,996
|
|
|
$
|
420,351
|
|
|
(1)
|
Including policyholder account balances ceded.
|
|
|
As of
March 31, 2019
|
||
|
Total of the three largest receivable balances from non-affiliated reinsurers
|
$
|
100,125
|
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||||||
|
|
Specialty Insurance
|
|
Other
(1)
|
|
Total
|
|
Specialty Insurance
|
|
Other
(1)
|
|
Total
|
||||||||||||
|
Customer relationships
|
$
|
50,500
|
|
|
$
|
—
|
|
|
$
|
50,500
|
|
|
$
|
50,500
|
|
|
$
|
—
|
|
|
$
|
50,500
|
|
|
Accumulated amortization
|
(20,264
|
)
|
|
—
|
|
|
(20,264
|
)
|
|
(18,913
|
)
|
|
—
|
|
|
(18,913
|
)
|
||||||
|
Trade names
|
6,500
|
|
|
800
|
|
|
7,300
|
|
|
6,500
|
|
|
800
|
|
|
7,300
|
|
||||||
|
Accumulated amortization
|
(2,864
|
)
|
|
(300
|
)
|
|
(3,164
|
)
|
|
(2,727
|
)
|
|
(280
|
)
|
|
(3,007
|
)
|
||||||
|
Software licensing
|
8,500
|
|
|
640
|
|
|
9,140
|
|
|
8,500
|
|
|
640
|
|
|
9,140
|
|
||||||
|
Accumulated amortization
|
(7,367
|
)
|
|
(343
|
)
|
|
(7,710
|
)
|
|
(6,942
|
)
|
|
(320
|
)
|
|
(7,262
|
)
|
||||||
|
Insurance policies and contracts acquired
|
36,500
|
|
|
—
|
|
|
36,500
|
|
|
36,500
|
|
|
—
|
|
|
36,500
|
|
||||||
|
Accumulated amortization
|
(35,965
|
)
|
|
—
|
|
|
(35,965
|
)
|
|
(35,898
|
)
|
|
—
|
|
|
(35,898
|
)
|
||||||
|
Insurance licensing agreements
(2)
|
13,761
|
|
|
—
|
|
|
13,761
|
|
|
13,761
|
|
|
—
|
|
|
13,761
|
|
||||||
|
Intangible assets, net
|
49,301
|
|
|
797
|
|
|
50,098
|
|
|
51,281
|
|
|
840
|
|
|
52,121
|
|
||||||
|
Goodwill
|
89,854
|
|
|
1,708
|
|
|
91,562
|
|
|
89,854
|
|
|
1,708
|
|
|
91,562
|
|
||||||
|
Total goodwill and intangible assets, net
|
$
|
139,155
|
|
|
$
|
2,505
|
|
|
$
|
141,660
|
|
|
$
|
141,135
|
|
|
$
|
2,548
|
|
|
$
|
143,683
|
|
|
(1)
|
Other is primarily comprised of mortgage operations.
|
|
(2)
|
Represents intangible assets with an indefinite useful life. Impairment tests are performed at least annually on these assets.
|
|
|
Specialty Insurance
|
|
Other
|
|
Total
|
||||||
|
Balance at December 31, 2018
|
$
|
89,854
|
|
|
$
|
1,708
|
|
|
$
|
91,562
|
|
|
Balance at March 31, 2019
|
$
|
89,854
|
|
|
$
|
1,708
|
|
|
$
|
91,562
|
|
|
|
|
|
|
|
|
||||||
|
Accumulated impairments
|
$
|
—
|
|
|
$
|
699
|
|
|
$
|
699
|
|
|
|
Specialty Insurance
|
|
Other
|
|
Total
|
||||||
|
Balance at December 31, 2018
|
$
|
51,281
|
|
|
$
|
840
|
|
|
$
|
52,121
|
|
|
Less: amortization expense
|
(1,980
|
)
|
|
(43
|
)
|
|
(2,023
|
)
|
|||
|
Balance at March 31, 2019
|
$
|
49,301
|
|
|
$
|
797
|
|
|
$
|
50,098
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Amortization expense on intangible assets
|
$
|
2,023
|
|
|
$
|
2,475
|
|
|
|
As of March 31, 2019
|
||||||||||
|
|
Specialty Insurance
|
|
Other
|
|
Total
|
||||||
|
Remainder of 2019
|
$
|
5,746
|
|
|
$
|
128
|
|
|
$
|
5,874
|
|
|
2020
|
5,150
|
|
|
171
|
|
|
5,321
|
|
|||
|
2021
|
4,333
|
|
|
171
|
|
|
4,504
|
|
|||
|
2022
|
3,649
|
|
|
126
|
|
|
3,775
|
|
|||
|
2023
|
3,212
|
|
|
80
|
|
|
3,292
|
|
|||
|
2024 and thereafter
|
13,450
|
|
|
121
|
|
|
13,571
|
|
|||
|
Total
|
$
|
35,540
|
|
|
$
|
797
|
|
|
$
|
36,337
|
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||||||
|
|
Notional
values |
|
Asset
derivatives |
|
Liability
derivatives |
|
Notional
values |
|
Asset
derivatives |
|
Liability
derivatives |
||||||||||||
|
Interest rate risk:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest rate lock commitments
|
$
|
184,074
|
|
|
$
|
5,494
|
|
|
$
|
—
|
|
|
$
|
122,477
|
|
|
$
|
3,460
|
|
|
$
|
—
|
|
|
Forward delivery contracts
|
47,402
|
|
|
—
|
|
|
55
|
|
|
41,383
|
|
|
5
|
|
|
52
|
|
||||||
|
TBA mortgage backed securities
|
163,000
|
|
|
138
|
|
|
1,086
|
|
|
129,000
|
|
|
39
|
|
|
824
|
|
||||||
|
Total
|
$
|
394,476
|
|
|
$
|
5,632
|
|
|
$
|
1,141
|
|
|
$
|
292,860
|
|
|
$
|
3,504
|
|
|
$
|
876
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Gains (losses) recognized in AOCI on the derivative-effective portion
|
$
|
—
|
|
|
$
|
1,111
|
|
|
|
|
|
|
||||
|
(Gains) losses reclassified from AOCI into income-effective portion
|
$
|
—
|
|
|
$
|
(3,845
|
)
|
|
|
|
|
|
Stated interest rate or range of rates
|
|
Maximum borrowing capacity as of
|
|
As of
|
||||||||
|
Debt Type
|
|
Stated maturity date
|
|
|
March 31, 2019
|
|
March 31, 2019
|
|
December 31, 2018
|
|||||||
|
Corporate debt
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Secured corporate credit agreements
|
|
April 2019 - September 2020
|
|
LIBOR + 1.00% to 5.50%
|
|
$
|
131,120
|
|
|
$
|
78,683
|
|
|
$
|
72,090
|
|
|
Junior subordinated notes
|
|
October 2057
|
|
8.50%
|
|
125,000
|
|
|
125,000
|
|
|
125,000
|
|
|||
|
Preferred trust securities
|
|
June 2037
|
|
LIBOR + 4.10%
|
|
35,000
|
|
|
35,000
|
|
|
35,000
|
|
|||
|
Total corporate debt
|
|
|
|
|
|
|
|
238,683
|
|
|
232,090
|
|
||||
|
Asset based debt
(1)
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Asset based revolving financing
(2)
|
|
April 2019
|
|
LIBOR + 2.60%
|
|
25,000
|
|
|
6,769
|
|
|
86,092
|
|
|||
|
Residential mortgage warehouse borrowings
(3)
|
|
May 2019 - August 2019
|
|
LIBOR + 2.00% to 2.50%
|
|
76,000
|
|
|
45,693
|
|
|
46,091
|
|
|||
|
Total asset based debt
|
|
|
|
|
|
|
|
52,462
|
|
|
132,183
|
|
||||
|
Total debt, face value
|
|
|
|
|
|
|
|
291,145
|
|
|
364,273
|
|
||||
|
Unamortized discount, net
|
|
|
|
|
|
|
|
(428
|
)
|
|
(504
|
)
|
||||
|
Unamortized deferred financing costs
|
|
|
|
|
|
|
|
(7,919
|
)
|
|
(9,686
|
)
|
||||
|
Total debt, net
|
|
|
|
|
|
|
|
$
|
282,798
|
|
|
$
|
354,083
|
|
||
|
(1)
|
Asset based debt is generally recourse only to specific assets and related cash flows.
|
|
(2)
|
The weighted average coupon rate for asset based revolving financing was
5.09%
and
4.30%
at
March 31, 2019
and
December 31, 2018
, respectively.
|
|
(3)
|
The weighted average coupon rate for residential mortgage warehouse borrowings was
4.63%
and
4.66%
at
March 31, 2019
and
December 31, 2018
, respectively.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Interest expense - corporate debt
|
$
|
4,994
|
|
|
$
|
3,852
|
|
|
Interest expense - asset based debt
|
1,926
|
|
|
2,094
|
|
||
|
Interest expense on debt
|
$
|
6,920
|
|
|
$
|
5,946
|
|
|
|
March 31, 2019
|
||
|
Remainder of 2019
|
$
|
60,025
|
|
|
2020
|
71,120
|
|
|
|
2021
|
—
|
|
|
|
2022
|
—
|
|
|
|
2023
|
—
|
|
|
|
2024 and thereafter
|
160,000
|
|
|
|
Total
|
$
|
291,145
|
|
|
|
As of March 31, 2019
|
||||||||||||||
|
|
Quoted prices in
active markets
Level 1
|
|
Other significant
observable inputs
Level 2
|
|
Significant unobservable inputs
Level 3
|
|
Fair value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Available for sale securities, at fair value:
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities and obligations of U.S. government authorities and agencies
|
$
|
—
|
|
|
$
|
79,285
|
|
|
$
|
—
|
|
|
$
|
79,285
|
|
|
Obligations of state and political subdivisions
|
—
|
|
|
63,782
|
|
|
—
|
|
|
63,782
|
|
||||
|
Obligations of foreign governments
|
—
|
|
|
4,893
|
|
|
—
|
|
|
4,893
|
|
||||
|
Certificates of deposit
|
1,096
|
|
|
—
|
|
|
—
|
|
|
1,096
|
|
||||
|
Asset backed securities
|
—
|
|
|
39,642
|
|
|
1,549
|
|
|
41,191
|
|
||||
|
Corporate securities
|
—
|
|
|
93,682
|
|
|
—
|
|
|
93,682
|
|
||||
|
Total available for sale securities, at fair value
|
1,096
|
|
|
281,284
|
|
|
1,549
|
|
|
283,929
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Loans, at fair value:
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Corporate loans
|
—
|
|
|
7,331
|
|
|
39,763
|
|
|
47,094
|
|
||||
|
Mortgage loans held for sale
|
—
|
|
|
53,512
|
|
|
—
|
|
|
53,512
|
|
||||
|
Non-performing loans
|
—
|
|
|
—
|
|
|
24,539
|
|
|
24,539
|
|
||||
|
Total loans, at fair value
|
—
|
|
|
60,843
|
|
|
64,302
|
|
|
125,145
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Equity securities
|
6,610
|
|
|
115,630
|
|
|
352
|
|
|
122,592
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Other investments, at fair value
|
—
|
|
|
138
|
|
|
10,867
|
|
|
11,005
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Total
|
$
|
7,706
|
|
|
$
|
457,895
|
|
|
$
|
77,070
|
|
|
$
|
542,671
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Derivative liabilities (included in other liabilities and accrued expenses)
|
—
|
|
|
1,141
|
|
|
—
|
|
|
1,141
|
|
||||
|
Total
|
$
|
—
|
|
|
$
|
1,141
|
|
|
$
|
—
|
|
|
$
|
1,141
|
|
|
|
As of December 31, 2018
|
||||||||||||||
|
|
Quoted prices in
active markets
Level 1
|
|
Other significant
observable inputs
Level 2
|
|
Significant unobservable inputs
Level 3
|
|
Fair value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Available for sale securities, at fair value:
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities and obligations of U.S. government authorities and agencies
|
$
|
—
|
|
|
$
|
71,748
|
|
|
$
|
—
|
|
|
$
|
71,748
|
|
|
Obligations of state and political subdivisions
|
—
|
|
|
67,446
|
|
|
—
|
|
|
67,446
|
|
||||
|
Obligations of foreign governments
|
—
|
|
|
6,751
|
|
|
—
|
|
|
6,751
|
|
||||
|
Certificates of deposit
|
1,241
|
|
|
—
|
|
|
—
|
|
|
1,241
|
|
||||
|
Asset backed securities
|
—
|
|
|
39,144
|
|
|
1,508
|
|
|
40,652
|
|
||||
|
Corporate bonds
|
—
|
|
|
95,725
|
|
|
—
|
|
|
95,725
|
|
||||
|
Total available for sale securities, at fair value
|
1,241
|
|
|
280,814
|
|
|
1,508
|
|
|
283,563
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Loans, at fair value:
|
|
|
|
|
|
|
|
||||||||
|
Corporate loans
|
—
|
|
|
22,697
|
|
|
108,213
|
|
|
130,910
|
|
||||
|
Mortgage loans held for sale
|
—
|
|
|
56,917
|
|
|
—
|
|
|
56,917
|
|
||||
|
Non-performing loans
|
—
|
|
|
—
|
|
|
27,556
|
|
|
27,556
|
|
||||
|
Total loans, at fair value
|
—
|
|
|
79,614
|
|
|
135,769
|
|
|
215,383
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Equity securities
|
9,323
|
|
|
113,138
|
|
|
518
|
|
|
122,979
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Other investments, at fair value
|
—
|
|
|
44
|
|
|
8,487
|
|
|
8,531
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Total
|
$
|
10,564
|
|
|
$
|
473,610
|
|
|
$
|
146,282
|
|
|
$
|
630,456
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Derivative liabilities (included in other liabilities and accrued expenses)
|
$
|
—
|
|
|
$
|
876
|
|
|
$
|
—
|
|
|
$
|
876
|
|
|
Total
|
$
|
—
|
|
|
$
|
876
|
|
|
$
|
—
|
|
|
$
|
876
|
|
|
|
Three Months Ended
March 31,
|
||||||
|
|
2019
(1)
|
|
2018
(1)
|
||||
|
Balance at January 1,
|
$
|
146,282
|
|
|
$
|
162,666
|
|
|
Net realized gains (losses)
|
118
|
|
|
(77
|
)
|
||
|
Net unrealized gains (losses)
|
644
|
|
|
1,106
|
|
||
|
Origination of IRLC
|
14,817
|
|
|
11,372
|
|
||
|
Purchases
|
—
|
|
|
23,298
|
|
||
|
Sales
(1)
|
(68,896
|
)
|
|
(22,633
|
)
|
||
|
Issuances
|
65
|
|
|
77
|
|
||
|
Transfer into Level 3
(1)
|
6,110
|
|
|
7,624
|
|
||
|
Transfer adjustments (out of) Level 3
(1)
|
(7,329
|
)
|
|
(7,420
|
)
|
||
|
Conversion to real estate owned
|
(1,958
|
)
|
|
(3,435
|
)
|
||
|
Conversion to mortgage loans held for sale
|
(12,783
|
)
|
|
(12,061
|
)
|
||
|
Balance at March 31,
|
$
|
77,070
|
|
|
$
|
160,517
|
|
|
|
|
|
|
||||
|
Changes in unrealized gains (losses) included in earnings related to assets still held at period end
|
$
|
(635
|
)
|
|
$
|
1,105
|
|
|
(1)
|
All transfers are deemed to occur at end of period. Transfers between Level 2 and 3 were a result of subjecting third-party pricing on assets to various liquidity, depth, bid-ask spread and benchmarking criteria as well as assessing the availability of observable inputs affecting their fair valuation.
|
|
|
Fair Value as of
|
|
|
|
|
|
Actual or Range
(Weighted average)
|
||||||||
|
Assets
|
March 31, 2019
|
|
December 31, 2018
|
|
Valuation technique
|
|
Unobservable input(s)
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Interest rate lock commitments
|
$
|
5,494
|
|
|
$
|
3,460
|
|
|
Internal model
|
|
Pull through rate
|
|
50% - 95%
|
|
50% - 95%
|
|
NPLs
|
24,539
|
|
|
27,556
|
|
|
Discounted cash flow
|
|
See table below
(1)
|
|
See table below
|
|
See table below
|
||
|
Total
|
$
|
30,033
|
|
|
$
|
31,016
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Significant changes in any of these inputs in isolation could result in a significant change to the fair value measurement. A decline in the discount rate in isolation would increase the fair value. A decrease in the housing pricing index in isolation would decrease the fair value. Individual loan characteristics, such as location and value of underlying collateral, affect the loan resolution timeline. An increase in the loan resolution timeline in isolation would decrease the fair value. A decrease in the value of underlying properties in isolation would decrease the fair value.
|
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||
|
Unobservable inputs
|
|
High
|
|
Low
|
|
Average
(1)
|
|
High
|
|
Low
|
|
Average
(1)
|
|
Discount rate
|
|
30.0%
|
|
16.0%
|
|
23.3%
|
|
30.0%
|
|
16.0%
|
|
23.6%
|
|
Loan resolution time-line (Years)
|
|
2.3
|
|
0.6
|
|
1.3
|
|
2.1
|
|
0.6
|
|
1.2
|
|
Value of underlying properties
|
|
$1,780
|
|
$55
|
|
$376
|
|
$1,780
|
|
$55
|
|
$383
|
|
Holding costs
|
|
14.2%
|
|
5.3%
|
|
7.1%
|
|
14.7%
|
|
5.0%
|
|
6.9%
|
|
Liquidation costs
|
|
14.2%
|
|
8.4%
|
|
9.2%
|
|
14.2%
|
|
8.4%
|
|
9.2%
|
|
Note rate
|
|
6.0%
|
|
3.0%
|
|
4.9%
|
|
6.0%
|
|
3.0%
|
|
4.9%
|
|
Secondary market transaction prices/UPB
|
|
88.3%
|
|
74.5%
|
|
83.3%
|
|
88.3%
|
|
74.5%
|
|
83.3%
|
|
(1)
|
Weighted based on value of underlying properties.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2019
|
|
As of December 31, 2018
|
||||||||||||||||
|
|
Level within
fair value
hierarchy
|
|
Fair value
|
|
Carrying value
|
|
Level within
fair value
hierarchy
|
|
Fair value
|
|
Carrying value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Debentures
|
2
|
|
$
|
5,182
|
|
|
$
|
5,182
|
|
|
2
|
|
$
|
5,134
|
|
|
$
|
5,134
|
|
|
Notes and accounts receivable, net
|
2
|
|
16,338
|
|
|
16,338
|
|
|
2
|
|
13,057
|
|
|
13,057
|
|
||||
|
Total assets
|
|
|
$
|
21,520
|
|
|
$
|
21,520
|
|
|
|
|
$
|
18,191
|
|
|
$
|
18,191
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Debt, net
|
3
|
|
$
|
295,092
|
|
|
$
|
290,717
|
|
|
3
|
|
$
|
363,769
|
|
|
$
|
363,769
|
|
|
Total liabilities
|
|
|
$
|
295,092
|
|
|
$
|
290,717
|
|
|
|
|
$
|
363,769
|
|
|
$
|
363,769
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Policy liabilities and unpaid claims balance as of January 1,
|
$
|
131,611
|
|
|
$
|
112,003
|
|
|
Less : liabilities of policy-holder accounts balances, gross
|
(13,659
|
)
|
|
(15,474
|
)
|
||
|
Less : non-insurance warranty benefit claim liabilities
|
(94
|
)
|
|
(58
|
)
|
||
|
Gross liabilities for unpaid losses and loss adjustment expenses
|
117,858
|
|
|
96,471
|
|
||
|
Less : reinsurance recoverable on unpaid losses - short duration
|
(90,016
|
)
|
|
(73,778
|
)
|
||
|
Less : other lines, gross
|
(227
|
)
|
|
(224
|
)
|
||
|
Net balance as of January 1, short duration
|
27,615
|
|
|
22,469
|
|
||
|
|
|
|
|
||||
|
Incurred (short duration) related to:
|
|
|
|
||||
|
Current year
|
33,137
|
|
|
25,002
|
|
||
|
Prior years
|
2,362
|
|
|
6,966
|
|
||
|
Total incurred
|
35,499
|
|
|
31,968
|
|
||
|
|
|
|
|
||||
|
Paid (short duration) related to:
|
|
|
|
||||
|
Current year
|
29,713
|
|
|
14,434
|
|
||
|
Prior years
|
4,973
|
|
|
14,179
|
|
||
|
Total paid
|
34,686
|
|
|
28,613
|
|
||
|
|
|
|
|
||||
|
Net balance as of March 31, short duration
|
28,428
|
|
|
25,824
|
|
||
|
Plus : reinsurance recoverable on unpaid losses - short duration
|
88,695
|
|
|
76,619
|
|
||
|
Plus : other lines, gross
|
230
|
|
|
172
|
|
||
|
Gross liabilities for unpaid losses and loss adjustment expenses
|
117,353
|
|
|
102,615
|
|
||
|
Plus : liabilities of policy-holder accounts balances, gross
|
13,138
|
|
|
15,048
|
|
||
|
Plus : non-insurance warranty benefit claim liabilities
|
94
|
|
|
77
|
|
||
|
Policy liabilities and unpaid claims balance as of March 31,
|
$
|
130,585
|
|
|
$
|
117,740
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Short duration incurred
|
$
|
35,499
|
|
|
$
|
31,968
|
|
|
Other lines incurred
|
—
|
|
|
46
|
|
||
|
Unallocated loss adjustment expense
|
294
|
|
|
698
|
|
||
|
Total losses incurred
|
$
|
35,793
|
|
|
$
|
32,712
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Asset management fee income
|
$
|
1,267
|
|
|
$
|
1,577
|
|
|
Warranty coverage revenue
|
6,822
|
|
|
6,123
|
|
||
|
Car club revenue
|
8,701
|
|
|
7,829
|
|
||
|
Other
|
1,708
|
|
|
2,097
|
|
||
|
Revenue from contracts with customers
|
$
|
18,498
|
|
|
$
|
17,626
|
|
|
|
January 1, 2019
|
|
|
|
|
|
March 31, 2019
|
||||||||
|
|
Beginning balance
|
|
Additions
|
|
Amortizations
|
|
Ending balance
|
||||||||
|
Deferred costs
|
|
|
|
|
|
|
|
||||||||
|
Warranty coverage revenue
|
$
|
1,274
|
|
|
$
|
79
|
|
|
$
|
267
|
|
|
$
|
1,086
|
|
|
Car club revenue
|
12,189
|
|
|
5,662
|
|
|
6,608
|
|
|
11,243
|
|
||||
|
Total
|
$
|
13,463
|
|
|
$
|
5,741
|
|
|
$
|
6,875
|
|
|
$
|
12,329
|
|
|
Deferred revenue
|
|
|
|
|
|
|
|
||||||||
|
Warranty coverage revenue
|
$
|
39,835
|
|
|
$
|
9,092
|
|
|
$
|
6,822
|
|
|
$
|
42,105
|
|
|
Car club revenue
|
16,128
|
|
|
7,456
|
|
|
8,701
|
|
|
14,883
|
|
||||
|
Total
|
$
|
55,963
|
|
|
$
|
16,548
|
|
|
$
|
15,523
|
|
|
$
|
56,988
|
|
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Right of use asset - Operating leases
(1)
|
$
|
29,564
|
|
|
$
|
—
|
|
|
Furniture, fixtures and equipment, net
|
8,876
|
|
|
6,122
|
|
||
|
Prepaid expenses
|
7,079
|
|
|
7,351
|
|
||
|
Income tax receivable
|
2,098
|
|
|
2,307
|
|
||
|
Subsidiary sale receivable
(2)
|
1,000
|
|
|
10,676
|
|
||
|
Other
|
21,848
|
|
|
19,578
|
|
||
|
Total other assets
|
$
|
70,465
|
|
|
$
|
46,034
|
|
|
(1)
|
See Note
(2) Summary of Significant Accounting Policies
and Note
(20) Commitments and Contingencies
for additional information.
|
|
(2)
|
Related to the gain contingency on sale of Care recorded in December 2018.
$9,676
was received in cash in January 2019. The remaining amount is expected to be paid off by 2021. See Note
(3) Dispositions, Assets Held for Sale & Discontinued Operations
.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Depreciation expense related to furniture, fixtures and equipment
|
$
|
479
|
|
|
$
|
497
|
|
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Accounts payable and accrued expenses
|
$
|
70,822
|
|
|
$
|
63,755
|
|
|
Operating lease liability
(1)
|
31,473
|
|
|
—
|
|
||
|
Deferred tax liabilities, net
|
26,864
|
|
|
25,433
|
|
||
|
Commissions payable
|
9,602
|
|
|
11,076
|
|
||
|
Accrued interest payable
|
5,111
|
|
|
3,452
|
|
||
|
Other
|
19,352
|
|
|
20,474
|
|
||
|
Total other liabilities and accrued expenses
|
$
|
163,224
|
|
|
$
|
124,190
|
|
|
(1)
|
See Note
(2) Summary of Significant Accounting Policies
and Note
(20) Commitments and Contingencies
for additional information.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Other investment income
(1)
|
$
|
9,881
|
|
|
$
|
5,108
|
|
|
Management fee income
|
1,267
|
|
|
1,577
|
|
||
|
Other
(2)
|
931
|
|
|
1,294
|
|
||
|
Total other revenue
|
$
|
12,079
|
|
|
$
|
7,979
|
|
|
(1)
|
See Note
(5) Investments
for the components of Other investment income.
|
|
(2)
|
Includes
$841
and
$696
related to Specialty Insurance for the
three months ended March 31, 2019
and
2018
, respectively.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Professional fees
|
$
|
4,176
|
|
|
$
|
5,001
|
|
|
General and administrative
|
4,984
|
|
|
3,820
|
|
||
|
Premium taxes
|
3,324
|
|
|
3,622
|
|
||
|
Mortgage origination expenses
|
2,478
|
|
|
2,183
|
|
||
|
Rent and related
|
3,277
|
|
|
2,379
|
|
||
|
Loss on extinguishment of debt
|
1,241
|
|
|
428
|
|
||
|
Other
|
4,357
|
|
|
1,732
|
|
||
|
Total other expenses
|
$
|
23,837
|
|
|
$
|
19,165
|
|
|
|
Three Months Ended
March 31, 2019 |
|
As of
March 31, 2019
|
|||||||
|
|
Number of shares purchased
|
|
Average price per share
|
|
Remaining repurchase authorization
|
|||||
|
Share repurchase programs:
|
60,421
|
|
|
$
|
5.86
|
|
|
$
|
9,277
|
|
|
Block repurchase program
|
1,412,309
|
|
|
6.18
|
|
|
10,000
|
|
||
|
Total
|
1,472,730
|
|
|
$
|
6.17
|
|
|
$
|
19,277
|
|
|
|
Dividends per share for the
|
||||||
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
First Quarter
(1)
|
$
|
0.040
|
|
|
$
|
0.035
|
|
|
The following table presents the dividends paid to our insurance holding company by its regulated insurance company subsidiaries for the following periods:
|
|||||||
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Ordinary dividends
|
$
|
9,001
|
|
|
$
|
—
|
|
|
Extraordinary dividends
|
1,188
|
|
|
—
|
|
||
|
Total dividends
|
$
|
10,189
|
|
|
$
|
—
|
|
|
|
As of
|
||||||
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Combined statutory capital and surplus of the Company's insurance company subsidiaries
|
$
|
122,471
|
|
|
$
|
131,859
|
|
|
|
|
|
|
||||
|
Required minimum statutory capital and surplus
|
$
|
17,950
|
|
|
$
|
17,950
|
|
|
|
|
|
|
||||
|
Amount available for ordinary dividends of the Company's insurance company subsidiaries
|
$
|
4,531
|
|
|
$
|
13,532
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net income of statutory insurance companies
|
$
|
951
|
|
|
$
|
6,172
|
|
|
|
Unrealized gains (losses) on
|
|
Amount attributable to noncontrolling interests
|
|
|
||||||||||||||||||
|
|
Available for sale securities
|
|
Interest rate swaps
|
|
Total AOCI (loss)
|
|
TFP
|
|
Other
|
|
Total AOCI (loss) to Tiptree Inc.
|
||||||||||||
|
Balance at December 31, 2017
|
$
|
(460
|
)
|
|
$
|
2,074
|
|
|
$
|
1,614
|
|
|
$
|
(222
|
)
|
|
$
|
(426
|
)
|
|
$
|
966
|
|
|
Other comprehensive income (losses) before reclassifications
|
(1,789
|
)
|
|
835
|
|
|
(954
|
)
|
|
61
|
|
|
210
|
|
|
(683
|
)
|
||||||
|
Amounts reclassified from AOCI
|
415
|
|
|
—
|
|
|
415
|
|
|
—
|
|
|
—
|
|
|
415
|
|
||||||
|
Reclassification of AOCI - interest rate swaps
(1)
|
—
|
|
|
(2,909
|
)
|
|
(2,909
|
)
|
|
502
|
|
|
226
|
|
|
(2,181
|
)
|
||||||
|
Period change
|
(1,374
|
)
|
|
(2,074
|
)
|
|
(3,448
|
)
|
|
563
|
|
|
436
|
|
|
(2,449
|
)
|
||||||
|
Balance at March 31, 2018
|
$
|
(1,834
|
)
|
|
$
|
—
|
|
|
$
|
(1,834
|
)
|
|
$
|
341
|
|
|
$
|
10
|
|
|
$
|
(1,483
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Balance at December 31, 2018
|
$
|
(2,069
|
)
|
|
$
|
—
|
|
|
$
|
(2,069
|
)
|
|
$
|
—
|
|
|
$
|
11
|
|
|
$
|
(2,058
|
)
|
|
Other comprehensive income (losses) before reclassifications
|
2,415
|
|
|
—
|
|
|
2,415
|
|
|
—
|
|
|
(11
|
)
|
|
2,404
|
|
||||||
|
Amounts reclassified from AOCI
|
4
|
|
|
—
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
4
|
|
||||||
|
Period change
|
2,419
|
|
|
—
|
|
|
2,419
|
|
|
—
|
|
|
(11
|
)
|
|
2,408
|
|
||||||
|
Adoption of accounting standard
(2)
|
(99
|
)
|
|
—
|
|
|
(99
|
)
|
|
—
|
|
|
—
|
|
|
(99
|
)
|
||||||
|
Balance at March 31, 2019
|
$
|
251
|
|
|
$
|
—
|
|
|
$
|
251
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
251
|
|
|
(1)
|
Relates to the sale of Care. See Note
(3) Dispositions, Assets Held for Sale & Discontinued Operations
.
|
|
(2)
|
Amounts reclassified to retained earnings due to adoption of ASU 2018-02. See Note
(2) Summary of Significant Accounting Policies
.
|
|
|
Three Months Ended
March 31, |
Affected line item in condensed consolidated statement of operations
|
||||||
|
Components of AOCI
|
2019
|
|
2018
|
|||||
|
Unrealized gains (losses) on available for sale securities
|
$
|
(5
|
)
|
|
$
|
(527
|
)
|
Net realized and unrealized gains (losses)
|
|
Related tax (expense) benefit
|
1
|
|
|
112
|
|
Provision for income tax
|
||
|
Net of tax
|
$
|
(4
|
)
|
|
$
|
(415
|
)
|
|
|
|
|
|
|
|
||||
|
Reclassification of AOCI - interest rate swaps
(1)
|
$
|
—
|
|
|
$
|
3,845
|
|
Gain on sale of discontinued operations
|
|
Related tax (expense) benefit
|
—
|
|
|
(936
|
)
|
Provision for income tax
|
||
|
Net of tax
|
$
|
—
|
|
|
$
|
2,909
|
|
|
|
(1)
|
Relates to the sale of Care. See Note
(3) Dispositions, Assets Held for Sale & Discontinued Operations
.
|
|
|
Number of shares
(1)
|
|
|
Available for issuance as of December 31, 2018
|
5,474,214
|
|
|
RSU and option awards granted
|
(659,898
|
)
|
|
Available for issuance as of March 31, 2019
|
4,814,316
|
|
|
(1)
|
Excludes awards granted under the Company’s subsidiary incentive plans that are exchangeable for Tiptree Common Stock.
|
|
|
Number of shares issuable
|
|
Weighted average grant date fair value
|
|||
|
Unvested units as of December 31, 2018
|
676,630
|
|
|
$
|
6.27
|
|
|
Granted
(1)
|
434,083
|
|
|
6.24
|
|
|
|
Vested
|
(143,785
|
)
|
|
6.45
|
|
|
|
Unvested units as of March 31, 2019
|
966,928
|
|
|
$
|
6.23
|
|
|
(1)
|
Includes grants of
14,028
, shares of Common Stock to directors.
|
|
|
Grant date fair value of equity shares issuable
|
||
|
Unvested balance as of December 31, 2018
|
$
|
8,710
|
|
|
Granted
|
—
|
|
|
|
Vested
|
(4,644
|
)
|
|
|
Unvested balance as of March 31, 2019
|
$
|
4,066
|
|
|
Valuation Input
|
|
Three Months Ended March 31, 2019
|
|
Three Months Ended March 31, 2018
|
||||
|
|
|
Assumption
|
|
Average
|
|
Assumption
|
|
Average
|
|
Historical volatility
|
|
27.69%
|
|
N/A
|
|
30.63%
|
|
N/A
|
|
Risk-free rate
|
|
2.62%
|
|
N/A
|
|
2.85%
|
|
N/A
|
|
Dividend yield
|
|
2.21%
|
|
N/A
|
|
2.03%
|
|
N/A
|
|
Expected term (years)
|
|
|
|
6.5
|
|
|
|
6.5
|
|
|
Options outstanding
|
|
Weighted average exercise price (in dollars per stock option)
|
|
Weighted average grant date value (in dollars per stock option)
|
|
Options exercisable
|
||||||
|
Balance, December 31, 2018
(1)
|
1,064,527
|
|
|
$
|
6.24
|
|
|
$
|
2.61
|
|
|
—
|
|
|
Granted
|
225,815
|
|
|
6.26
|
|
|
1.69
|
|
|
—
|
|
||
|
Balance, March 31, 2019
|
1,290,342
|
|
|
6.24
|
|
|
2.45
|
|
|
—
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
Weighted average remaining contractual term at March 31, 2019 (in years)
|
8.2
|
|
|
|
|
|
|
|
|||||
|
(1)
|
Book value targets for grants in 2018, 2017, and 2016 are
$10.79
,
$9.97
, and
$10.14
, respectively.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Employee compensation and benefits
|
$
|
1,331
|
|
|
$
|
1,233
|
|
|
Director compensation
|
77
|
|
|
74
|
|
||
|
Income tax benefit
|
(304
|
)
|
|
(282
|
)
|
||
|
Net stock-based compensation expense
|
$
|
1,104
|
|
|
$
|
1,025
|
|
|
|
As of
|
||||||
|
|
March 31, 2019
|
||||||
|
|
Stock options
|
|
Restricted stock awards and RSUs
|
||||
|
Unrecognized compensation cost related to non-vested awards
|
$
|
1,449
|
|
|
$
|
6,973
|
|
|
Weighted - average recognition period (in years)
|
2.15
|
|
|
1.47
|
|
||
|
|
Three Months Ended
March 31, |
||||||||||
|
|
2019
|
|
2018
|
||||||||
|
Total income tax expense (benefit) from continuing operations
|
$
|
854
|
|
|
$
|
(1,568
|
)
|
||||
|
|
|
|
|
|
|
||||||
|
Effective tax rate (ETR)
|
16.6
|
%
|
(1)
|
|
22.3
|
%
|
(2)
|
||||
|
|
|
|
|
|
|
||||||
|
Income tax expense (benefit) from discontinued operations
|
$
|
—
|
|
|
$
|
12,327
|
|
||||
|
(1)
|
Lower than the U.S. federal statutory income tax rate of
21%
due to the effect of the dividends received deduction and other discrete items, partially offset by the impact of valuation allowance, state taxes, and the impact of foreign operations.
|
|
(2)
|
Higher than the U.S. federal statutory income tax rate of
21%
due to the effect of state income taxes and the dividends received deduction, partially offset by the impact of valuation allowance and other discrete items.
|
|
|
As of
March 31, 2019
|
||
|
Right of use asset - Operating leases
|
$
|
29,564
|
|
|
|
|
||
|
Operating lease liability
|
$
|
31,473
|
|
|
|
|
||
|
Weighted-average remaining lease term (years)
|
7.2
|
|
|
|
|
|
||
|
Weighted-average discount rate
(1)
|
7.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2019
|
||
|
Remainder of 2019
|
$
|
4,425
|
|
|
2020
|
6,597
|
|
|
|
2021
|
6,293
|
|
|
|
2022
|
5,020
|
|
|
|
2023
|
4,394
|
|
|
|
2024 and thereafter
|
15,925
|
|
|
|
Total minimum payments
|
42,654
|
|
|
|
Less: liabilities held for sale
|
(601
|
)
|
|
|
Less: present value adjustment
|
(10,580
|
)
|
|
|
Total
|
$
|
31,473
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Rent expense for office leases
|
$
|
2,349
|
|
|
$
|
1,495
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net income (loss) from continuing operations
|
$
|
4,301
|
|
|
$
|
(5,475
|
)
|
|
Less:
|
|
|
|
||||
|
Net income (loss) attributable to non-controlling interests
|
376
|
|
|
(1,116
|
)
|
||
|
Net income allocated to participating securities
|
85
|
|
|
—
|
|
||
|
Net income (loss) from continuing operations attributable to Common Shares
|
3,840
|
|
|
(4,359
|
)
|
||
|
|
|
|
|
||||
|
Net income (loss) from discontinued operations
|
—
|
|
|
34,481
|
|
||
|
Less:
|
|
|
|
||||
|
Net income (loss) from discontinued operations attributable to non-controlling interests
|
—
|
|
|
6,562
|
|
||
|
Net income allocated to participating securities
|
—
|
|
|
—
|
|
||
|
Net income (loss) from discontinued operations attributable to Common Shares
|
—
|
|
|
27,919
|
|
||
|
Net income (loss) attributable to Common Shares - basic
|
$
|
3,840
|
|
|
$
|
23,560
|
|
|
Effect of Dilutive Securities:
|
|
|
|
||||
|
Securities of subsidiaries
|
(170
|
)
|
|
—
|
|
||
|
Adjustments to income relating to exchangeable interests, net of tax
|
—
|
|
|
—
|
|
||
|
Net income (loss) attributable to Common Shares - diluted
|
$
|
3,670
|
|
|
$
|
23,560
|
|
|
|
|
|
|
||||
|
Weighted average number of shares of Common Stock outstanding - basic
|
34,673,054
|
|
|
29,861,496
|
|
||
|
Weighted average number of incremental shares of Common Stock issuable from exchangeable interests and contingent considerations
|
—
|
|
|
—
|
|
||
|
Weighted average number of shares of Common Stock outstanding - diluted
|
34,673,054
|
|
|
29,861,496
|
|
||
|
|
|
|
|
||||
|
Basic:
|
|
|
|
||||
|
Net income (loss) from continuing operations
|
$
|
0.11
|
|
|
$
|
(0.15
|
)
|
|
Net income (loss) from discontinued operations
|
—
|
|
|
0.94
|
|
||
|
Net income (loss) attributable to Common Shares
|
$
|
0.11
|
|
|
$
|
0.79
|
|
|
|
|
|
|
||||
|
Diluted:
|
|
|
|
||||
|
Net income (loss) from continuing operations
|
$
|
0.11
|
|
|
$
|
(0.15
|
)
|
|
Net income (loss) from discontinued operations
|
—
|
|
|
0.94
|
|
||
|
Net income (loss) attributable to Common Shares
|
$
|
0.11
|
|
|
$
|
0.79
|
|
|
•
|
Overview
|
|
•
|
Results of Operations
|
|
•
|
Non-GAAP Reconciliations
|
|
•
|
Liquidity and Capital Resources
|
|
•
|
Critical Accounting Policies and Estimates
|
|
•
|
Off-Balance Sheet Arrangements
|
|
•
|
Delivered a quarterly return of 3.1%, as measured by growth in book value per share plus dividends paid.
|
|
•
|
Year-to-date 2019, we purchased and retired 1,472,730 shares of our Common Stock for $9.1 million through open market purchases and block purchases.
|
|
•
|
Increased our quarterly dividend for the third consecutive year to $0.04 per share, a 14.3% increase.
|
|
•
|
Gross written premiums for first quarter 2019 were
$198.4 million
, down 1.1% from the prior year. Net written premiums were
$121.0 million
, up 10.8%, driven by growth in credit and warranty products.
|
|
•
|
Within our insurance investment portfolio, we reduced our exposure to levered credit by selling approximately $80.0 million of assets and repaying asset-based debt.
|
|
•
|
In 2019, began re-positioning our asset management platform, by agreeing to invest $75 million to seed new investment funds in exchange for management control of, and a profit participation in, Corvid Peak (formerly known as Tricadia).
|
|
($ in millions, except per share information)
|
Three Months Ended
March 31, |
||||||
|
GAAP:
|
2019
|
|
2018
|
||||
|
Total revenues
|
$
|
183.9
|
|
|
$
|
148.1
|
|
|
Net income (loss) before non-controlling interests
|
4.3
|
|
|
29.0
|
|
||
|
Net income (loss) attributable to Common Stockholders
|
3.9
|
|
|
23.6
|
|
||
|
Diluted earnings per share
|
0.11
|
|
|
0.79
|
|
||
|
Cash dividends paid per common share
|
—
|
|
|
—
|
|
||
|
|
|
|
|
||||
|
Non-GAAP:
(1)
|
|
|
|
||||
|
Operating EBITDA
|
12.6
|
|
|
8.9
|
|
||
|
Adjusted EBITDA
|
14.6
|
|
|
5.4
|
|
||
|
Book value per share
(2)
|
11.12
|
|
|
10.59
|
|
||
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net realized and unrealized gains (losses)
(1)
|
$
|
4.0
|
|
|
$
|
(7.7
|
)
|
|
Discontinued operations (Care)
(2)
|
$
|
—
|
|
|
$
|
46.8
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Specialty Insurance
|
$
|
8.1
|
|
|
$
|
1.3
|
|
|
Tiptree Capital
|
5.9
|
|
|
(1.7
|
)
|
||
|
Corporate
|
(8.9
|
)
|
|
(6.7
|
)
|
||
|
Pre-tax income (loss) from continuing operations
|
$
|
5.1
|
|
|
$
|
(7.1
|
)
|
|
Pre-tax income (loss) from discontinued operations
(1)
|
$
|
—
|
|
|
$
|
46.8
|
|
|
(1)
|
Represents Care for the
three months ended March 31, 2018
which includes
$46.2 million
pre-tax gain on sale.
|
|
|
As of March 31,
|
||||||||||||||
|
($ in millions)
|
Invested Capital
|
|
Total Capital
|
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Specialty Insurance
|
$
|
297.6
|
|
|
$
|
281.5
|
|
|
$
|
465.2
|
|
|
$
|
441.5
|
|
|
Tiptree Capital
|
175.9
|
|
|
147.2
|
|
|
175.9
|
|
|
147.2
|
|
||||
|
Corporate
|
(40.9
|
)
|
|
15.2
|
|
|
30.2
|
|
|
43.2
|
|
||||
|
Total Tiptree
|
$
|
432.6
|
|
|
$
|
443.9
|
|
|
$
|
671.3
|
|
|
$
|
631.9
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Specialty Insurance
|
$
|
13.7
|
|
|
$
|
13.3
|
|
|
Tiptree Capital
(2)
|
4.7
|
|
|
3.3
|
|
||
|
Corporate
|
(5.8
|
)
|
|
(7.7
|
)
|
||
|
Operating EBITDA
|
$
|
12.6
|
|
|
$
|
8.9
|
|
|
Stock-based compensation expense
|
(1.4
|
)
|
|
(1.2
|
)
|
||
|
Vessel depreciation, net of capital expenditures
|
(0.6
|
)
|
|
—
|
|
||
|
Realized and unrealized gains (losses)
(3)
|
4.0
|
|
|
(2.2
|
)
|
||
|
Third party non-controlling interests
(4)
|
—
|
|
|
(0.1
|
)
|
||
|
Adjusted EBITDA
|
$
|
14.6
|
|
|
$
|
5.4
|
|
|
(1)
|
For further information relating to Invested Capital, Total Capital, Operating EBITDA and Adjusted EBITDA, including a reconciliation to GAAP total stockholders equity and pre-tax income, see “—Non-GAAP Reconciliations.”
|
|
(2)
|
Includes discontinued operations related to Care for the 2018 period. As of February 1, 2018, invested capital from Care discontinued operations is represented by our Invesque common shares. For more information, see “Note—
(3) Dispositions, Assets Held for Sale & Discontinued Operations
.”
|
|
(3)
|
Excludes Mortgage realized and unrealized gains and losses - Performing and NPLs.
|
|
(4)
|
Removes the Operating EBITDA associated with third party non-controlling interests. Does not remove the non-controlling interests related to employee based shares.
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Gross written premiums
|
$
|
198.4
|
|
|
$
|
200.7
|
|
|
Net written premiums
|
121.0
|
|
|
109.2
|
|
||
|
Revenues:
|
|
|
|
||||
|
Net earned premiums
|
$
|
119.0
|
|
|
$
|
101.6
|
|
|
Service and administrative fees
|
25.9
|
|
|
24.6
|
|
||
|
Ceding commissions
|
2.5
|
|
|
2.3
|
|
||
|
Net investment income
|
4.3
|
|
|
4.2
|
|
||
|
Net realized and unrealized gains (losses)
|
2.1
|
|
|
(3.4
|
)
|
||
|
Other income
|
0.8
|
|
|
0.7
|
|
||
|
Total revenues
|
$
|
154.6
|
|
|
$
|
130.0
|
|
|
Expenses:
|
|
|
|
||||
|
Policy and contract benefits
|
40.8
|
|
|
36.6
|
|
||
|
Commission expense
|
74.9
|
|
|
62.6
|
|
||
|
Employee compensation and benefits
|
12.0
|
|
|
10.9
|
|
||
|
Interest expense
|
4.1
|
|
|
4.5
|
|
||
|
Depreciation and amortization expenses
|
2.3
|
|
|
2.7
|
|
||
|
Other expenses
|
12.4
|
|
|
11.4
|
|
||
|
Total expenses
|
$
|
146.5
|
|
|
$
|
128.7
|
|
|
Pre-tax income (loss)
|
$
|
8.1
|
|
|
$
|
1.3
|
|
|
|
Three months ended March 31,
|
||||||||||||||
|
|
Gross Written Premiums
|
|
Net Written Premiums
|
||||||||||||
|
Insurance Products:
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Credit protection
|
$
|
132.3
|
|
|
$
|
116.9
|
|
|
$
|
89.0
|
|
|
$
|
76.7
|
|
|
Warranty
|
41.6
|
|
|
25.7
|
|
|
22.8
|
|
|
15.5
|
|
||||
|
Other specialty programs
|
24.5
|
|
|
58.1
|
|
|
9.2
|
|
|
17.0
|
|
||||
|
Total
|
$
|
198.4
|
|
|
$
|
200.7
|
|
|
$
|
121.0
|
|
|
$
|
109.2
|
|
|
|
Three months ended March 31,
|
||||||||||||||
|
|
Underwriting Revenues
|
|
Underwriting Margin
|
||||||||||||
|
Insurance products:
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Credit protection
|
$
|
106.4
|
|
|
$
|
92.7
|
|
|
$
|
19.5
|
|
|
$
|
18.1
|
|
|
Warranty
|
28.5
|
|
|
22.2
|
|
|
8.5
|
|
|
6.4
|
|
||||
|
Other specialty programs
|
10.9
|
|
|
12.0
|
|
|
2.0
|
|
|
3.0
|
|
||||
|
Services and other
|
2.4
|
|
|
2.3
|
|
|
2.5
|
|
|
2.5
|
|
||||
|
Total
|
$
|
148.2
|
|
|
$
|
129.2
|
|
|
$
|
32.5
|
|
|
$
|
30.0
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Invested Capital
(1)
|
$
|
297.6
|
|
|
$
|
281.5
|
|
|
Total Capital
(1)
|
$
|
465.2
|
|
|
$
|
441.5
|
|
|
|
|
|
|
||||
|
Operating EBITDA drivers:
|
|
|
|
||||
|
Underwriting
|
$
|
9.8
|
|
|
$
|
9.2
|
|
|
Investments
|
3.9
|
|
|
4.1
|
|
||
|
Specialty Insurance Operating EBITDA
(1)
|
$
|
13.7
|
|
|
$
|
13.3
|
|
|
Insurance operating ratios:
|
|
|
|
||||
|
Combined ratio
|
93.5
|
%
|
|
93.8
|
%
|
||
|
($ in millions)
|
As of March 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Cash and cash equivalents
(1)
|
$
|
61.1
|
|
|
$
|
29.1
|
|
|
Available for sale securities, at fair value
|
283.9
|
|
|
212.8
|
|
||
|
Equity securities
|
27.0
|
|
|
34.3
|
|
||
|
Loans, at fair value
(2)
|
71.6
|
|
|
90.0
|
|
||
|
Real estate, net
|
9.9
|
|
|
16.8
|
|
||
|
Other investments
|
8.9
|
|
|
16.7
|
|
||
|
Net investments
|
$
|
462.4
|
|
|
$
|
399.7
|
|
|
|
|
|
|
||||
|
(1) Cash and cash equivalents, plus restricted cash, net of due from/due to brokers on consolidated loan funds, see “—Non-GAAP Reconciliations”, for a reconciliation to GAAP financials.
|
|||||||
|
(2) Loans, at fair value, net of asset based debt, see “—Non-GAAP Reconciliations”, for a reconciliation to GAAP financials.
|
|||||||
|
|
|||||||
|
Specialty Insurance Net Investment Portfolio Income - Non-GAAP
|
|||||||
|
|
|
|
|
||||
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net investment income
|
$
|
4.3
|
|
|
$
|
4.2
|
|
|
Realized gains (losses)
|
0.2
|
|
|
5.1
|
|
||
|
Unrealized gains (losses)
|
1.9
|
|
|
(8.5
|
)
|
||
|
Interest expense
|
(0.6
|
)
|
|
(1.2
|
)
|
||
|
Net portfolio income (loss)
|
$
|
5.8
|
|
|
$
|
(0.4
|
)
|
|
Average Annualized Yield %
(1)
|
5.0
|
%
|
|
(0.4
|
)%
|
||
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Total revenues
|
$
|
29.3
|
|
|
$
|
18.1
|
|
|
Pre-tax income (loss) from continuing operations
|
$
|
5.9
|
|
|
$
|
(1.7
|
)
|
|
Pre-tax income (loss) from discontinued operations
|
$
|
—
|
|
|
$
|
46.8
|
|
|
|
|
|
|
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Asset management fees and credit investments
|
$
|
0.5
|
|
|
$
|
0.9
|
|
|
Shipping
|
0.5
|
|
|
(0.8
|
)
|
||
|
Specialty finance and other
|
0.3
|
|
|
(0.1
|
)
|
||
|
Senior Living:
|
|
|
|
||||
|
Invesque
(1)
|
4.6
|
|
|
(1.6
|
)
|
||
|
Care - discontinued operations
(2)
|
—
|
|
|
46.8
|
|
||
|
($ in millions)
|
Invested Capital
(1)
|
|
Operating EBITDA
(1)
|
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Asset management fees and credit investments
(2)
|
$
|
2.4
|
|
|
$
|
4.2
|
|
|
$
|
0.6
|
|
|
$
|
0.9
|
|
|
Senior living (Invesque)
(3)
|
97.5
|
|
|
105.9
|
|
|
2.5
|
|
|
2.3
|
|
||||
|
Shipping
|
48.7
|
|
|
—
|
|
|
1.1
|
|
|
—
|
|
||||
|
Specialty finance and other
|
27.3
|
|
|
41.3
|
|
|
0.5
|
|
|
0.1
|
|
||||
|
Tiptree Capital
|
$
|
175.9
|
|
|
$
|
151.4
|
|
|
$
|
4.7
|
|
|
$
|
3.3
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Employee compensation and benefits
|
$
|
1.8
|
|
|
$
|
1.4
|
|
|
Employee incentive compensation expense
|
2.0
|
|
|
2.3
|
|
||
|
Interest expense
|
1.6
|
|
|
0.6
|
|
||
|
Depreciation and amortization expenses
|
0.1
|
|
|
0.1
|
|
||
|
Other expenses
|
3.4
|
|
|
2.3
|
|
||
|
Total expenses
|
$
|
8.9
|
|
|
$
|
6.7
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2019
|
||||||||||||||
|
|
Specialty Insurance
|
|
Tiptree Capital
|
|
Corporate
|
|
Total
|
||||||||
|
Total assets
|
$
|
1,450.8
|
|
|
$
|
320.3
|
|
|
$
|
43.8
|
|
|
$
|
1,814.9
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Corporate debt
|
$
|
167.6
|
|
|
$
|
—
|
|
|
$
|
71.1
|
|
|
$
|
238.7
|
|
|
Asset based debt
|
6.8
|
|
|
45.7
|
|
|
—
|
|
|
52.5
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Tiptree Inc. stockholders’ equity
|
$
|
248.8
|
|
|
$
|
175.9
|
|
|
$
|
(41.1
|
)
|
|
$
|
383.6
|
|
|
Non-controlling interests - Other
|
8.8
|
|
|
2.2
|
|
|
—
|
|
|
11.0
|
|
||||
|
Total stockholders’ equity
|
$
|
257.6
|
|
|
$
|
178.1
|
|
|
$
|
(41.1
|
)
|
|
$
|
394.6
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net income (loss) attributable to Common Stockholders
|
$
|
3.9
|
|
|
$
|
23.6
|
|
|
Add: net (loss) income attributable to noncontrolling interests
|
0.4
|
|
|
5.4
|
|
||
|
Less: net income from discontinued operations
|
—
|
|
|
34.5
|
|
||
|
Income (loss) from continuing operations
|
$
|
4.3
|
|
|
$
|
(5.5
|
)
|
|
Corporate Debt related interest expense
(1)
|
5.0
|
|
|
3.8
|
|
||
|
Consolidated income tax expense (benefit)
|
0.9
|
|
|
(1.6
|
)
|
||
|
Depreciation and amortization expense
(2)
|
3.0
|
|
|
2.8
|
|
||
|
Non-cash fair value adjustments
(3)
|
(0.6
|
)
|
|
0.1
|
|
||
|
Non-recurring expenses
(4)
|
2.0
|
|
|
(0.3
|
)
|
||
|
Adjusted EBITDA from continuing operations
|
$
|
14.6
|
|
|
$
|
(0.7
|
)
|
|
Add: Stock-based compensation expense
|
1.4
|
|
|
1.2
|
|
||
|
Add: Vessel depreciation, net of capital expenditures
|
0.6
|
|
|
—
|
|
||
|
Less: Realized and unrealized gain (loss)
(5)
|
4.0
|
|
|
(7.7
|
)
|
||
|
Less: Third party non-controlling interests
(6)
|
—
|
|
|
(0.1
|
)
|
||
|
Operating EBITDA from continuing operations
|
$
|
12.6
|
|
|
$
|
8.3
|
|
|
|
|
|
|
||||
|
Income (loss) from discontinued operations
|
$
|
—
|
|
|
$
|
34.5
|
|
|
Consolidated income tax expense (benefit)
|
—
|
|
|
12.3
|
|
||
|
Non-cash fair value adjustments
(3)
|
—
|
|
|
(40.7
|
)
|
||
|
Adjusted EBITDA from discontinued operations
|
$
|
—
|
|
|
$
|
6.1
|
|
|
Less: Realized and unrealized gain (loss)
(5)
|
—
|
|
|
5.5
|
|
||
|
Operating EBITDA from discontinued operations
|
$
|
—
|
|
|
$
|
0.6
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Total Adjusted EBITDA
|
$
|
14.6
|
|
|
$
|
5.4
|
|
|
Total Operating EBITDA
|
$
|
12.6
|
|
|
$
|
8.9
|
|
|
(1)
|
Corporate Debt interest expense includes Secured corporate credit agreements, junior subordinated notes and preferred trust securities. Interest expense associated with asset-specific debt in specialty insurance and asset management, mortgage and other operations is not added-back for Adjusted EBITDA and Operating EBITDA.
|
|
(2)
|
Represents total depreciation and amortization expense less purchase accounting amortization related adjustments at the Insurance Company. Following the purchase accounting adjustments, current period expenses associated with deferred costs were more favorably stated and current period income associated with deferred revenues were less favorably stated. Thus, the purchase accounting effect related to our Insurance company increased EBITDA above what the historical basis of accounting would have generated.
|
|
(3)
|
For our specialty insurance operations, depreciation and amortization on senior living real estate that is within net investment income is added back to Adjusted EBITDA. For Care (Discontinued Operations), the reduction in EBITDA is related to accumulated depreciation and amortization, and certain operating expenses, which were previously included in Adjusted EBITDA in prior periods.
|
|
(4)
|
Acquisition, start-up and disposition costs including debt extinguishment, legal, taxes, banker fees and other costs. In 2018, includes payments pursuant to a separation agreement, dated November 10, 2015.
|
|
(5)
|
Adjustment excludes Mortgage realized and unrealized gains and losses - Performing and NPLs as those are recurring in nature and align with those business models.
|
|
(6)
|
Removes the Operating EBITDA associated with third party non-controlling interests. Does not remove the non-controlling interests related to employee based shares.
|
|
|
Three Months Ended March 31, 2019
|
||||||||||||||
|
($ in millions)
|
Specialty Insurance
|
|
Tiptree Capital
(1)
|
|
Corporate Expenses
|
|
Total
|
||||||||
|
Pre-tax income/(loss) from continuing ops
|
$
|
8.1
|
|
|
$
|
5.9
|
|
|
$
|
(8.9
|
)
|
|
$
|
5.1
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
||||||||
|
Corporate Debt related interest expense
(2)
|
3.4
|
|
|
—
|
|
|
1.6
|
|
|
5.0
|
|
||||
|
Depreciation and amortization expenses
(3)
|
2.2
|
|
|
0.8
|
|
|
0.1
|
|
|
3.1
|
|
||||
|
Non-cash fair value adjustments
(4)
|
—
|
|
|
(0.6
|
)
|
|
—
|
|
|
(0.6
|
)
|
||||
|
Non-recurring expenses
(5)
|
1.3
|
|
|
—
|
|
|
0.7
|
|
|
2.0
|
|
||||
|
Adjusted EBITDA
|
$
|
15.0
|
|
|
$
|
6.1
|
|
|
$
|
(6.5
|
)
|
|
$
|
14.6
|
|
|
Add: Stock-based compensation expense
|
0.6
|
|
|
0.1
|
|
|
0.7
|
|
|
1.4
|
|
||||
|
Add: Vessel depreciation, net of capital expenditures
|
—
|
|
|
0.6
|
|
|
—
|
|
|
0.6
|
|
||||
|
Less: Realized and unrealized gain (loss)
(6)
|
1.9
|
|
|
2.1
|
|
|
—
|
|
|
4.0
|
|
||||
|
Operating EBITDA
|
$
|
13.7
|
|
|
$
|
4.7
|
|
|
$
|
(5.8
|
)
|
|
$
|
12.6
|
|
|
|
Three Months Ended March 31, 2018
|
||||||||||||||
|
($ in millions)
|
Specialty Insurance
|
|
Tiptree Capital
(1)
|
|
Corporate Expenses
|
|
Total
|
||||||||
|
Pre-tax income/(loss) from continuing ops
|
$
|
1.3
|
|
|
$
|
(1.7
|
)
|
|
$
|
(6.7
|
)
|
|
$
|
(7.1
|
)
|
|
Pre-tax income/(loss) from discontinued ops
|
—
|
|
|
46.8
|
|
|
—
|
|
|
46.8
|
|
||||
|
Adjustments:
|
|
|
|
|
|
|
|
||||||||
|
Corporate Debt related interest expense
(2)
|
3.2
|
|
|
—
|
|
|
0.6
|
|
|
3.8
|
|
||||
|
Depreciation and amortization expenses
(3)
|
2.5
|
|
|
0.2
|
|
|
0.1
|
|
|
2.8
|
|
||||
|
Non-cash fair value adjustments
(4)
|
0.1
|
|
|
(40.7
|
)
|
|
—
|
|
|
(40.6
|
)
|
||||
|
Non-recurring expenses
(5)
|
1.1
|
|
|
0.9
|
|
|
(2.3
|
)
|
|
(0.3
|
)
|
||||
|
Adjusted EBITDA
|
$
|
8.2
|
|
|
$
|
5.5
|
|
|
$
|
(8.3
|
)
|
|
$
|
5.4
|
|
|
Add: Stock-based compensation expense
|
0.6
|
|
|
$
|
—
|
|
|
0.6
|
|
|
1.2
|
|
|||
|
Less: Realized and unrealized gain (loss)
(6)
|
(4.5
|
)
|
|
2.3
|
|
|
—
|
|
|
(2.2
|
)
|
||||
|
Less: Third party non-controlling interests
(7)
|
—
|
|
|
(0.1
|
)
|
|
—
|
|
|
(0.1
|
)
|
||||
|
Operating EBITDA
|
$
|
13.3
|
|
|
$
|
3.3
|
|
|
$
|
(7.7
|
)
|
|
$
|
8.9
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Includes discontinued operations related to Care. For more information, see “Note—
(3) Dispositions, Assets Held for Sale & Discontinued Operations
.”
|
|
(2)
|
Corporate Debt interest expense includes Secured corporate credit agreements, junior subordinated notes and preferred trust securities. Interest expense associated with asset-specific debt in specialty insurance and asset management, mortgage and other operations is not added-back for Adjusted EBITDA and Operating EBITDA.
|
|
(3)
|
Represents total depreciation and amortization expense less purchase accounting amortization related adjustments at the Insurance Company. Following the purchase accounting adjustments, current period expenses associated with deferred costs were more favorably stated and current period income associated with deferred revenues were less favorably stated. Thus, the purchase accounting effect related to our Insurance company increased EBITDA above what the historical basis of accounting would have generated.
|
|
(4)
|
For our specialty insurance operations, depreciation and amortization on senior living real estate that is within net investment income is added back to Adjusted EBITDA. For Care (Discontinued Operations), the reduction in EBITDA is related to accumulated depreciation and amortization, and certain operating expenses, which were previously included in Adjusted EBITDA in prior periods.
|
|
(5)
|
Acquisition, start-up and disposition costs including debt extinguishment, legal, taxes, banker fees and other costs. In 2018, includes payments pursuant to a separation agreement, dated November 10, 2015.
|
|
(6)
|
Adjustment excludes Mortgage realized and unrealized gains and losses - Performing and NPLs as those are recurring in nature and align with those business models.
|
|
(7)
|
Removes the Operating EBITDA associated with third party non-controlling interests. Does not remove the non-controlling interests related to employee based shares.
|
|
($ in millions, except per share information)
|
As of March 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Total stockholders’ equity
|
$
|
394.6
|
|
|
$
|
407.7
|
|
|
Less non-controlling interest - other
|
11.0
|
|
|
5.4
|
|
||
|
Total stockholders’ equity, net of non-controlling interests - other
|
$
|
383.6
|
|
|
$
|
402.3
|
|
|
Total Common shares outstanding
|
34.5
|
|
|
29.9
|
|
||
|
Total Class B shares outstanding
|
—
|
|
|
8.0
|
|
||
|
Total shares outstanding
|
34.5
|
|
|
37.9
|
|
||
|
Book value per share
(1)
|
$
|
11.12
|
|
|
$
|
10.59
|
|
|
($ in millions)
|
As of March 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Total stockholders’ equity
|
$
|
394.6
|
|
|
$
|
407.7
|
|
|
Less non-controlling interest - other
|
11.0
|
|
|
5.4
|
|
||
|
Total stockholders’ equity, net of non-controlling interests - other
|
$
|
383.6
|
|
|
$
|
402.3
|
|
|
Plus Specialty Insurance accumulated depreciation and amortization, net of tax
|
44.8
|
|
|
37.6
|
|
||
|
Plus acquisition costs
|
4.2
|
|
|
4.2
|
|
||
|
Invested Capital
|
$
|
432.6
|
|
|
$
|
444.1
|
|
|
Plus corporate debt
|
238.7
|
|
|
188.0
|
|
||
|
Total Capital
|
$
|
671.3
|
|
|
$
|
632.1
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
Revenues:
|
2019
|
|
2018
|
||||
|
Net earned premiums
|
$
|
119.0
|
|
|
$
|
101.6
|
|
|
Service and administrative fees
|
25.9
|
|
|
24.6
|
|
||
|
Ceding commissions
|
2.5
|
|
|
2.3
|
|
||
|
Other income
|
0.8
|
|
|
0.7
|
|
||
|
Underwriting Revenues - Non-GAAP
|
$
|
148.2
|
|
|
$
|
129.2
|
|
|
Less underwriting expenses:
|
|
|
|
||||
|
Policy and contract benefits
|
40.8
|
|
|
36.6
|
|
||
|
Commission expense
|
74.9
|
|
|
62.6
|
|
||
|
Underwriting Margin - Non-GAAP
|
$
|
32.5
|
|
|
$
|
30.0
|
|
|
Less operating expenses:
|
|
|
|
||||
|
Employee compensation and benefits
|
12.0
|
|
|
10.9
|
|
||
|
Other expenses (excluding debt extinguishment expenses)
|
11.1
|
|
|
10.8
|
|
||
|
Combined Ratio
|
93.5
|
%
|
|
93.8
|
%
|
||
|
Plus investment revenues:
|
|
|
|
||||
|
Net investment income
|
4.3
|
|
|
4.2
|
|
||
|
Net realized and unrealized gains
|
2.1
|
|
|
(3.4
|
)
|
||
|
Less other expenses:
|
|
|
|
||||
|
Interest expense
|
4.1
|
|
|
4.5
|
|
||
|
Debt extinguishment expenses
|
1.2
|
|
|
0.4
|
|
||
|
Depreciation and amortization expenses
|
2.3
|
|
|
2.7
|
|
||
|
Pre-tax income (loss)
|
$
|
8.1
|
|
|
$
|
1.3
|
|
|
($ in millions)
|
As of March 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
Total Investments
|
$
|
401.3
|
|
|
$
|
467.2
|
|
|
Investment portfolio debt
(1)
|
—
|
|
|
(96.6
|
)
|
||
|
Cash and cash equivalents
|
58.7
|
|
|
27.2
|
|
||
|
Restricted cash
(2)
|
1.0
|
|
|
3.1
|
|
||
|
Receivable due from brokers
(3)
|
1.4
|
|
|
2.9
|
|
||
|
Liability due to brokers
(3)
|
—
|
|
|
(4.2
|
)
|
||
|
Net investments - Non-GAAP
|
$
|
462.4
|
|
|
$
|
399.6
|
|
|
($ in millions)
|
|
Corporate Debt outstanding as of March 31,
|
|
Interest expense for the three months ended March 31,
|
||||||||||||
|
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
|
Specialty insurance
|
|
$
|
167.6
|
|
|
$
|
160.0
|
|
|
$
|
3.4
|
|
|
$
|
3.2
|
|
|
Corporate
|
|
71.1
|
|
|
28.0
|
|
|
1.6
|
|
|
0.6
|
|
||||
|
Total
|
|
$
|
238.7
|
|
|
$
|
188.0
|
|
|
$
|
5.0
|
|
|
$
|
3.8
|
|
|
($ in millions)
|
Three Months Ended
March 31, |
||||||
|
Total cash provided by (used in):
|
2019
|
|
2018
|
||||
|
Operating activities
|
(8.2
|
)
|
|
3.5
|
|
||
|
Investing activities
|
94.7
|
|
|
(21.0
|
)
|
||
|
Financing activities
|
(82.0
|
)
|
|
(32.8
|
)
|
||
|
Net increase (decrease) in cash, cash equivalents and restricted cash
|
$
|
4.5
|
|
|
$
|
(50.3
|
)
|
|
($ in millions)
|
Less than 1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than 5 years
|
|
Total
|
||||||||||
|
Corporate Debt
|
$
|
7.6
|
|
|
$
|
71.1
|
|
|
$
|
—
|
|
|
$
|
160.0
|
|
|
$
|
238.7
|
|
|
Asset Based Debt
|
52.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
52.5
|
|
|||||
|
Total Debt
|
$
|
60.1
|
|
|
$
|
71.1
|
|
|
$
|
—
|
|
|
$
|
160.0
|
|
|
$
|
291.2
|
|
|
Operating lease obligations
(2)
|
6.1
|
|
|
12.7
|
|
|
9.0
|
|
|
14.8
|
|
|
42.6
|
|
|||||
|
Total
|
$
|
66.2
|
|
|
$
|
83.8
|
|
|
$
|
9.0
|
|
|
$
|
174.8
|
|
|
$
|
333.8
|
|
|
(1)
|
See Note
(10) Debt, net
, in the accompanying consolidated financial statements for additional information.
|
|
(2)
|
Minimum rental obligation for office leases. The total rent expense for the
three months ended March 31, 2019
and
2018
was
$2.3 million
and
$1.5 million
, respectively.
|
|
•
|
Note
(9) Derivative Financial Instruments and Hedging
|
|
•
|
Note
(20) Commitments and Contingencies
|
|
Period
|
Purchaser
|
Total
Number of
Shares
Purchased
(1)
|
Average
Price
Paid Per
Share
|
Total Number
of Shares
Purchased
as Part of
Publicly
Announced
Plans or
Programs
|
Approximate
Dollar Value of
Shares That
May Yet Be
Purchased
Under the
Plans or
Programs
(2)
|
||||||
|
January 1, 2019 to January 31, 2019: Open Market and Block Purchases
|
Tiptree Inc.
|
1,462,730
|
|
$
|
6.17
|
|
1,462,730
|
|
$
|
19,342,560
|
|
|
February 1, 2019 to February 28, 2019: Open Market Purchases
|
Tiptree Inc.
|
10,000
|
|
$
|
6.06
|
|
10,000
|
|
$
|
19,281,960
|
|
|
March 1, 2019 to March 31, 2019
|
Tiptree Inc.
|
—
|
|
$
|
—
|
|
—
|
|
$
|
19,281,960
|
|
|
|
Total
|
1,472,730
|
|
$
|
—
|
|
1,472,730
|
|
$
|
—
|
|
|
(1)
|
On December 7, 2018, Tiptree engaged a broker in connection with a share repurchase program for the repurchase of up to $10 million of its outstanding Common Stock. On February 5, 2019, the Company terminated such share repurchase program as it had purchased substantial blocks of shares through privately negotiated transactions.
|
|
(2)
|
On December 7, 2018, the Board of Directors of Tiptree (“Board”) separately authorized Tiptree to make block repurchases of up to $10 million in the
|
|
The following documents are filed as a part of this Form 10-Q:
|
|
|
|
|
|
Financial Statements (Unaudited):
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018
|
|
|
Condensed Consolidated Statements of Operations for the three months ended March 31, 2019 and 2018
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2019 and 2018
|
|
|
Condensed Consolidated Statement of Changes in Stockholders’ Equity for the periods ended March 31, 2019 and 2018
|
|
|
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2019 and 2018
|
|
|
|
|
|
Exhibits:
|
|
|
The Exhibits listed in the Index of Exhibits, which appears immediately following the signature page, is incorporated herein by reference and is filed as part of this Form 10-Q.
|
|
|
|
|
|
Tiptree Inc.
|
|
|
|
|
|
|
|
|
Date:
|
May 6, 2019
|
|
By:/s/ Michael Barnes
|
|
|
|
|
|
Michael Barnes
|
|
|
|
|
|
Executive Chairman
|
|
|
|
|
|
|
|
|
Date:
|
May 6, 2019
|
|
By:/s/ Jonathan Ilany
|
|
|
|
|
|
Jonathan Ilany
|
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
|
Date:
|
May 6, 2019
|
|
By:/s/ Sandra Bell
|
|
|
|
|
|
Sandra Bell
|
|
|
|
|
|
Chief Financial Officer
|
|
|
Exhibit No.
|
Description
|
|
10.1
|
|
|
10.2
|
|
|
31.1
|
|
|
31.2
|
|
|
31.3
|
|
|
32.1
|
|
|
32.2
|
|
|
32.3
|
|
|
|
|
|
101.INS
|
XBRL Instance Document*
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document*
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document*
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document*
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document*
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document*
|
|
*
|
Attached as Exhibit 101 to this Quarterly Report on Form 10-Q are the following materials, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets for
March 31, 2019
and
December 31, 2018
, (ii) the Condensed Consolidated Statements of Operations for the
three months ended March 31, 2019
and
2018
, (iii) the Condensed Consolidated Statements of Comprehensive Income for the
three months ended March 31, 2019
and
2018
, (iv) the Condensed Consolidated Statements of Changes in Stockholders’ Equity for the period ended
March 31, 2019
and 2018, (v) the Condensed Consolidated Statements of Cash Flows for the
three months ended March 31, 2019
and
2018
and (vi) the Notes to the Condensed Consolidated Financial Statements.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|